Conference Agenda

The Indian Cancer Genetics and Genomics Conference-2020   The Indian Cancer Genetics and Genomics Conference-2020 (ICGGC-2020) was organized on a hybrid-virtual platform on the 24th and 25th of November 2020. This was organised by the Department of Medical Oncology, AIIMS, New Delhi in association with the Indo-UK Genetic Education Forum, under the aegis of the Research and Education Society of medical Oncology (RESMO). Genetics and genomics are playing an ever-increasing role in deciding the management of cancers, be it the diagnosis, prognosis, precision therapeutic management or precision prevention. The role of genomics and genetics in oncology is evolving at an extremely fast pace and it is prudent to keep abreast of it. Precision prevention, particularly identifying the high-risk families and unaffected relatives has a tremendous potential for preventing cancers and altering the natural history of the disease. With this intent in mind, this conference was planned to present the current state-of -the art management in Clinical Cancer Genetics. It was an educational event targeted to the residents training in medical, surgical, radiation oncology and gynaecological and breast surgery in different institutes all over the country. The conference had a galaxy of esteemed faculty, including renowned clinicians and geneticists from the United kingdom, the United Sates, leading academic institutes across the length and breadth of India including AIIMS-New Delhi, Tata Memorial Hospital-Mumbai, PGIMER-Chandigarh, JIPMER-Puducherry, Cancer Institute-Adyar, Chennai. The first day was dedicated to Hereditary breast and ovarian cancers and the speakers explained the current concepts and the state- of – the art practice. Important data from European and Indian studies were presented and discussed. Panel discussion explaining the important aspects of clinical management was organised. The second day was dedicated was Lynch syndrome, Li Fraumeni, Retinoblastoma and other miscellaneous cancers. The laboratory principles, technical details of reporting, genetic counselling etc were addressed. The event was attended online and appreciated by more than 800 viewers all over the world. The videos of the event, both days 1 & 2 are available at the link on the institute website.

Day 1: https://drive.google.com/file/d/1vQpvHhXdpYiTrqgoV_szWZsl1eqrj12z/view?usp=sharing   Day 2: https://drive.google.com/file/d/1ft2HFDx3pAUeWXKSt7nqDonAz2II1yev/view?usp=sharing

Name: Dr. Deepam Pushpam

Qualification: MD (Internal Medicine), DM (Medical Oncology)

Designation: Assistant Professor, Department of Medical Oncology.

Address: Room No. 245, Department of Medical Oncology 2nd Floor, Dr B.R.A-I.R.C.H, AIIMS , Ansari Nagar, New Delhi 110029.

Contact info: Email: deepampushpam@gmail.com

Academic career: Dr. Deepam Pushpam graduated from the Guwahati Medical College, Guwahati University and received his MD degree in Internal Medicine from AIIMS, Delhi. He did his senior resident ship in Medical oncology at the Dr. B. R. A- IRCH, AIIMS, New Delhi and completed his DM degree in Medical Oncology from AIIIMS. He was recruited as a faculty in Medical Oncology at the Dr. B R A –IRCH, AIIMS, New Delhi in 2018.

Area of Expertise: Dr. Deepam Pushpam is a member of the multidisciplinary teams at Dr. B.R.A-IRCH taking care of   pediatric solid cancer, soft tissue sarcoma, melanoma, pediatric and adult hematological malignancies and hematopoietic stem cell transplant. He routinely takes care of these patients in the OPD and wards. He has keen interest in hematopoietic stem cell transplant for congenital disorders in children, cord blood transplant, allogeneic hematopoietic stem cell transplant and haploidentical stem cell transplant. He also actively participates in clinical services for lung cancer.

Research interest: Acute lymphoblastic leukemia, chronic myeloid leukemia, rare pediatric tumors, and soft tissue sarcoma.

Awards:

1. Geeta Mittal Award for Best Research in Oncology AIIMS, Delhi 2018.
2. Best Thesis in Oncology ICON 2018

Membership of Professional bodies:

1.            Member: European Society for Medical Oncology, (ESMO).

2.            Member: Indian Society of Medical and Paediatric Oncology,(ISMPO)

3.            Member: Paediatric Hemato-Oncology chapter of Inadian Academy of Paediatrics (PHO-IAP)

Selected publications:

1. Pushpam, D., Bakhshi, S. Pharmacology of tyrosine kinase inhibitors in chronic myeloid leukemia; a clinician’s perspective. DARU J Pharm Sci (2020). doi.org/10.1007/s40199-019-00321-z
2. Pushpam D, Bakhshi S. Paediatric chronic myeloid leukaemia: Is it really a different disease?Indian J Med Res. 2019 May;149(5):600-609. doi: 10.4103/ijmr.IJMR_331_19. Review.
3. Pushpam D, Rajput N, Chopra A, Vishnubhatla S, Kumari M, Kumar R, Bakhshi S.Association of absolute lymphocyte count and peripheral blood lymphocyte subsets percentage with minimal residual disease at the end of induction in pediatric B cell acute lymphoblastic leukemia. Pediatr Hematol Oncol. 2019 Apr;36(3):138-150. doi: 10.1080/08880018.2019.1594469. Epub 2019 May 3.
4. Pushpam D, Chopra A, Sreenivas V, Kumar R, Bakhshi S.Absolute Lymphocyte Count at the End of Induction as a Surrogate Marker for Minimal Residual Disease in T-cell Acute Lymphoblastic Leukemia. Pushpam D, Chopra A, Sreenivas V, Kumar R, Bakhshi S. Indian Pediatr. 2019 May 15;56(5):381-383.
5. Ganguly S, Pushpam D, Mian A, Chopra A, Gupta R, Bakhshi S. Real-world Experience of Imatinib in Pediatric Chronic Phase Chronic Myeloid Leukemia: A Single-center Experience From India. Clin Lymphoma Myeloma Leuk. 2020 Mar 6. pii: S2152-2650(20)30112-9. doi: 10.1016/j.clml.2020.02.015.
6. Kancharla H, Gundu N, Pathak N, Vandidassane I, Khurana S, Pushpam D, Jain D, Kumar S, Pathy S, Mohan A, Malik PS.Cytotoxic chemotherapy in advanced non-small cell lung cancer with poor performance status: A retrospective analysis from routine clinical practice. Curr Probl Cancer. 2020 Jan 20:100550. doi: 10.1016/j.currproblcancer.2020.100550.Review.

 

BIOGRAPHICAL DATA   Name: Atul Batra Address: New Delhi, India Telephone/Email: +91-11-29575232/batraatul85@gmail.com Present rank: Associate Professor Department: Medical Oncology Faculty: Medicine Institution: All India Institute of Medical Sciences, New Delhi Date of Birth: 02 January 1986  Major clinical interests Dr.Batra is a member of the multidisciplinary teams at Dr. B.R.A-IRCH taking care of Breast cancer, and Genitourinary cancers and routinely takes care of these patients in the OPD and wards.   Major research interests Breast Cancer Prostate Cancer Renal Cell Cancer Urinary Bladder Cancer Germ Cell Tumor ACADEMIC RECORD   Post-Secondary Education Institution/University       Degree Subject/Area Dates   Maulana Azad Medical College, Delhi University  MBBS General Medicine and Surgery July 2003 to December 2008 All India Institute of Medical Sciences, New Delhi  MD Internal Medicine January 2009 to December 2011 All India Institute of Medical Sciences, New Delhi DM     Medical Oncology January 2013 to December 2015  Tom Baker Cancer Centre,Calgary, Canada   Fellowship Breast cancer and Health Services Research July 2019 to June 2020   Continuing Education and Training   Institution / University Rank or Title Dates  Maulana Azad Medical College, Delhi University, India   Intern January 2008 to December 2008  All India Institute of Medical Sciences, New Delhi, India  Senior Resident, Internal Medicine January 2012 to October 2012  All India Institute of Medical Sciences, New Delhi Senior resident, Medical Oncology January 2016 to November 2016  Second University of Naples, Italy Translational Research Unit Fellow    April 2016  Memorial Sloan Kettering Cancer Centre, New York, USA nternational CML Foundation Fellow  October 2017 to November 2017  Tom Baker Cancer Centre, University of Calgary Clinical and Research Fellow July 2019 to present   Stanford University Medical Statistics I-III (Certificate course)  May 2020-May 2021  All India Institute of Medical Sciences, new Delhi Part-time Fellowship in Research Methodology and Evidence Based Medicine January 2021-ongoing  Board Exams and Certifications  Year Board Exam/Certificate  2015 European Society of Medical Oncology Exam 2017 Diplomate of National Board (Medical Oncology), India 2017 Membership of the Royal Colleges of Physicians of the United Kingdom Speciality Certificate Exam (Medical Oncology) 2018 Membership of the Royal Colleges of Physicians of the United Kingdom Part 1 and 2  Medical Licensure Year Licensing Body Subject/Area 2008-present Delhi Medical Council General 2012-present Delhi Medical Council Specialist: Internal Medicine 2016-present Delhi Medical Council Specialist: Medical Oncology 2019-2020 College of Physicians and Surgeons of Alberta Post graduate medical trainee, Medical Oncology     ACADEMIC APPOINTMENTS    University, Company or Organization  Rank or Title Dates All India Institute of Medical Sciences, New Delhi, India  Associate Professor July 2020 to present All India Institute of Medical Sciences, New Delhi, India Assistant Professor November 2016 to June 2020    AWARDS AND DISTINCTIONS   Year Description City, Country 2021 ASCO International Innovation Grant USA 2020 Coltman Scholar Award at San Antonio Breast Cancer Symposium 2020 San Antonio, USA 2020 ASCO Merit Award in Quality Care Symposium 2020 Chicago, USA 2020 Novartis Oncology Young Canadian Investigator Award 2020 Calgary, Canada 2020 Young Investigator Award, ESMO World GI Congress 2020 Barcelona, Spain 2020 ASCO Merit Award at Annual ASCO meeting 2020 Chicago, USA 2020 ESMO Breast 2020 Merit Award- Travel Grant Berlin, Germany 2018 President Gold Medal for the Best Diplomate of National Board in Medical Oncology Delhi, India 2018 European Society of Medical Oncology (ESMO) Travel Award for Preceptorship on Breast Cancer Singapore 2018 European Society of Medical Oncology (ESMO) Travel Award for Preceptorship on Prostate Cancer Singapore 2017 International CML preceptorship award New York, USA 2017 Young Investigator Award at International Society of Paediatric Oncology Annual Meeting Washington DC, USA 2016 Department of Science and Technology International Travel Award Delhi, India 2016 Multinational Association of Supportive Care in Cancer Annual Meeting Scholarship Award Adelaide, Australia 2016 European Society of Medical Oncology (ESMO) Translational Research Fellowship Award Naples, Italy 2016 Gold medal (Smt. Shakuntala Jolly Award) for the Best DM student in Medical Oncology at All India Institute of Medical Sciences Delhi, India 2016 Best Clinical research (Smt. Geeta Mittal Award) in Oncology in All India Institute of Medical Sciences Delhi, India 2015 Young Investigator Award at International Society of Paediatric Oncology Annual Meeting Cape town, South Africa 2015 European Society of Medical Oncology (ESMO) Asia Annual Meeting Scholarship Award Singapore  2015 European Society of Medical Oncology (ESMO) Travel Award for Preceptorship on Prostate Cancer Prague, Czech Republic 2015 Indian Council for Medical Research International Travel Award for American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, USA 2015 European Society of Medical Oncology (ESMO) Travel Award for Preceptorship on Non-small Cell Lung Cancer Singapore 2014 Awarded first prize in oncology quiz at International Acute Lymphoblastic Leukaemia Conference Chennai, India 2014 European Society of Medical Oncology (ESMO) Travel Award for Preceptorship on Immuno-oncology Barcelona, Spain    PROFESSIONAL ACTIVITIES Current Memberships in Professional Societies American Society of Clinical Oncology (ASCO) Canadian Society of Medical Oncology (CAMO) European Society of Medical Oncology (ESMO) Indian Society of Medical and Paediatric Oncology (ISMPO) Multinational Association for Supportive Care in Cancer (MASCC) Invited Journal Reviews Journal of Global Oncology PLoS One British Medical Journal Case Reports Indian Journal of Medical and Paediatric Oncology National Medical Journal of India   RESEARCH PROJECTS   Ongoing Research Projects A. Investigator-initiated 1. Randomized double-blind placebo-controlled trial of topical 1% diclofenac in prevention of capecitabine induced hand foot syndrome 2. Assessment of serum tumor marker response in patients receiving neoadjuvant chemotherapy in triple negative breast cancer 3. Assessment of symptom burden in cancer patients through an innovative mobile-based patient-reported outcomes system in India Industry-sponsored (PI at site) 1. A Phase III Double-Blind, Randomised, Placebo-Controlled Study Assessing the Efficacy and Safety of Capivasertib + Abiraterone Versus Placebo + Abiraterone as Treatment for Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Characterised by PTEN deficiency (CAPItello-281). 2. A Phase III, Randomized, Open-Label, Controlled, Multi-Center, Global Study of First-Line Durvalumab in Combination with Standard of Care Chemotherapy and Durvalumab in Combination with Tremelimumab and Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone in Patients with Unresectable Locally Advanced or Metastatic Urothelial Cancer 3. SERENA-4: A Randomised, Multicentre, Double-Blind, Phase III Study of AZD9833 (an Oral SERD) plus Palbociclib versus Anastrazole plus Palbociclib for the Treatment of Patients with Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease Completed Year Project Role   2019 A multicenter phase 4, open-label, single-arm, safety and efficacy study of enzalutamide in indian patients With progressive metastatic castration-resistant prostate cancer previously treated with docetaxel-based chemotherapy principal investigator.  Principal Investigator for site 2017 Immunohistochemical expression of sirtuin-1 in osteosarcoma and correlation with survival outcomes. Principal Investigator  2017 A prospective, multicenter, randomized, double-blind, Parallel group study to compare the efficacy and Safety of GBR 200 (similar biologic of trastuzumab) Versus innovator trastuzumab, both when given in Combination with paclitaxel in patients diagnosed with Her2 positive metastatic breast cancer.  Co-Investigator 2017 A multicenter, open-label phase 2b study of selinexor (kpt-330) in patients with relapsed/refractory DLBCLwho have no therapeutic options of demonstrated clinical benefit. Co-Investigator 2016 Aprepitant as an add-on therapy in children receiving highly emetogenic chemotherapy: a randomized, double-blind, placebo-controlled trial. Co-Investigator 2015 Metronomic chemotherapy vs best supportive care inprogressive pediatric solid malignant tumors: a randomized clinical trial.  Research Staff Shikha Jain (Junior Research Fellow) Sneha Gund (Study Coordinator) Akansha Dhakolia (Study Nurse) Co-Investigator   INVITED ADRESSES Year Conference/Event Topic City, Country 2021 Best of SABCS New Delhi, India CDK4/6 inhibitors in adjuvant setting in patients with breast cancer Delhi, India 2020 Year in Review- Breast Cancer Newer therapies in HER2 positive breast cancer Mumbai, India 2018 Association of Breast Surgeons of India annual conference Optimizing adjuvant treatment in early breast cancer patients  Delhi, India 2018 International Precision Oncology & Breast Cancer Conference Role of comprehensive genomic sequencing in metastatic breast cancer Jaipur, India 2018 Best of San Antonio Breast Cancer Symposium Developments in metastatic hormone positive breast cancer in 2017 Delhi, India 2018 Treating Breast Cancer with Precision Optimizing neoadjuvant chemotherapy in HER2 positive breast cancer Chennai, India 2018 Updates in Breast Cancer by National Cancer Institute Contemporary management of early triple negative breast cancer: Medical Oncologist’s perspective Delhi, India 2018 Year in Review: Genitourinary Cancers Sequencing of treatment in metastatic prostate cancer Kolkata, India 2017 Updates in Gynaecological Cancers by National Cancer Institute Role of bevacizumab in cervical cancer Delhi, India 2017 Indian Gastrointestinal Oncology Meet Advances in treatment of metastatic colon cancer Mumbai, India 2017 Advances in Haematology Stopping Imatinib in CML: Is this the right time? Delhi, India 2017 36th ICON conference Immunotherapy in renal cell cancer: A new era Lucknow, India PUBLICATIONS AND PRESENTATIONS PubMed Indexed Publications Sharma A, Sahoo RK, Batra A. Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma. N Engl J Med. 2021 Nov 11;385(20):1919. doi: 10.1056/NEJMc2115204. PMID: 34758261. Blomstrand H, Batra A, Cheung WY, Elander NO. Real-world evidence on first- and second-line palliative chemotherapy in advanced pancreatic cancer. World J Clin Oncol. 2021 Sep 24;12(9):787-799. doi: 10.5306/wjco.v12.i9.787. PMID: 34631442; PMCID: PMC8479347. Mittal A, Deo SVS, Gogia A, Batra A, Kumar A, Bhoriwal S, Deb KS, Dhamija E, Thulkar S, Ramprasad VL, Olopade O, Pramanik R. Profile of Pathogenic Mutations and Evaluation of Germline Genetic Testing Criteria in Consecutive Breast Cancer Patients Treated at a North Indian Tertiary Care Center. Ann Surg Oncol. 2021 Oct 2:1–10. doi: 10.1245/s10434-021-10870-w. Epub ahead of print. PMID: 34601666; PMCID: PMC8487333. Batra A, Yusuf D, Hurry M, Walton RN, Devost N, Farrer C, Cheung WY. A Population-based Study of Treatment Patterns and Survival of Patients With De Novo Stage IV Non-Small Cell Lung Cancer. Am J Clin Oncol (e-pub ahead of print 11 August 2021; doi:10.1097/COC.0000000000000857) Batra A, Tang PA, Cheung WY. Prognostic Significance of Disease Control at 12 Weeks in Patients With Advanced Pancreatic Cancer Receiving FOLFIRINOX as First-line Chemotherapy. Am J Clin Oncol (e-pub ahead of print 9 August 2021; doi:10.1097/COC.0000000000000856). Gupta N, Gupta A, Sarma R, Batra A, Madan K. Video laryngoscopy vs. direct laryngoscopy for nasotracheal intubation in oro-maxillofacial surgery: a systematic review and meta-analysis of randomized controlled trials. Korean J Anesthesiol (e-pub ahead of print 9 August 2021; doi:10.4097/kja.21234). Batra A, Kong S, Cheung WY. Associations of Socioeconomic Status and Rurality With New-Onset Cardiovascular Disease in Cancer Survivors: A Population-Based Analysis. JCO Oncol Pract. 2021 Jul 9:OP2001053. doi: 10.1200/OP.20.01053. Epub ahead of print. PMID: 34242068. Amaro CP, Batra A, Lupichuk S. First-Line Treatment with a Cyclin-Dependent Kinase 4/6 Inhibitor Plus an Aromatase Inhibitor for Metastatic Breast Cancer in Alberta. Current Oncology 2021; 28: 2270–2280. [DOI: 10.3390/curroncol28030209] Batra A, Nixon NA, Roldan-Urgoiti G, Hannouf MB, Abedin T, Hugh J, King K, Bigras G, Steed T, Lupichuk S. Developing a clinical-pathologic model to predict genomic risk of recurrence in patients with hormone receptor positive, human epidermal growth factor receptor-2 negative, node negative breast cancer. Cancer Treat Res Commun 2021; 28: 100401. [PMID: 34091374 DOI: 10.1016/j.ctarc.2021.100401] Batra A, Yang L, Boyne DJ, Harper A, Cuthbert CA, Cheung WY. Symptom burden in patients with common cancers near end-of-life and its associations with clinical characteristics: a real-world study. Support Care Cancer 2021; 29: 3299–3309. [PMID: 33104922 DOI: 10.1007/s00520-020-05827-w] Singh TP, Sharma A, Sharma A, Bakhshi S, Patel C, Pandey AK, Dhamija E, Batra A, Kumar R. Utility of 18F-FDG-PET/CT in management and prognostication of treatment naïve late-stage soft tissue sarcomas. Nucl Med Commun 2021; 42: 818–825. [PMID: 33741856 DOI: 10.1097/MNM.0000000000001401] Batra A, Rigo R, Hannouf MB, Cheung WY. Real-world Safety and Efficacy of Raltitrexed in Patients With Metastatic Colorectal Cancer. Clin Colorectal Cancer 2021; 20: e75–e81. [PMID: 33268287 DOI: 10.1016/j.clcc.2020.09.006] Yadav S, Mathew R, Sahu AK, Jamshed N, Mohindra R, Aggarwal P, Batra A, Halder D, Brunda RL. Prognostic Value of Serum Procalcitonin Levels in Patients With Febrile Neutropenia Presenting to the Emergency Department. J Emerg Med 2021; 60: 641–647. [PMID: 33518374 DOI: 10.1016/j.jemermed.2020.12.010] Batra A, Cheung WY. Role of real-world evidence in informing cancer care: lessons from colorectal cancer. Curr Oncol 2019; 26: S53–S56. [PMID: 31819710 DOI: 10.3747/co.26.5625] Patel A, Gupta VG, Biswas B, Ganguly S, Das CK, Batra A, Bhethanabhotla S. Reply to D. O’Reilly et al. JCO Glob Oncol 2021; 7: 648. [PMID: 33956500 DOI: 10.1200/GO.21.00077] Hannouf M, Batra A, Lupichuk S. Four Cycles of Docetaxel-Cyclophosphamide versus Anthracycline-Taxane as Adjuvant Chemotherapy for HER2-Negative, Axillary Lymph Node Negative Breast Cancer: A Real-World Comparison of Alberta Patients Treated 2008-2012. Curr Oncol 2021; 28: 1137–1142. [PMID: 33806441 DOI: 10.3390/curroncol28020109] Boyne DJ, Cheung WY, Hilsden RJ, Sajobi TT, Batra A, Friedenreich CM, Brenner DR. Association of a Shortened Duration of Adjuvant Chemotherapy With Overall Survival Among Individuals With Stage III Colon Cancer. JAMA Netw Open 2021; 4: e213587. [PMID: 33783516 DOI: 10.1001/jamanetworkopen.2021.3587] Arora S, Kumar A, Batra A. Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Early Triple-Negative Breast Cancer. JAMA Oncol 2021; 7: 460–461. [PMID: 33410889 DOI: 10.1001/jamaoncol.2020.7157] Batra A, Yang L, Boyne DJ, Harper A, Cheung WY, Cuthbert CA. Associations between baseline symptom burden as assessed by patient-reported outcomes and overall survival of patients with metastatic cancer. Support Care Cancer 2021; 29: 1423–1431. [PMID: 32676854 DOI: 10.1007/s00520-020-05623-6] Batra A, McKinnon G, Billawala A, Sheka D, Kong S, Cheung WY. Factors associated with the initiation of chemotherapy within 90 days of death in metastatic colorectal cancer patients: a population-based study. Support Care Cancer 2021; 29: 1535–1542. [PMID: 32725376 DOI: 10.1007/s00520-020-05655-y] Batra A, Kumar A. HER2 positivity in patients with estrogen receptor (ER) positive breast cancer: Is it really prognostic? Breast 2021; 55: 136. [PMID: 33328129 DOI: 10.1016/j.breast.2020.11.017] Singh N, Batra A, Yang L, Boyne DJ, Harper A, Ghatage P, Cuthbert CA, Cheung WY. Patient-Reported Symptom Burden Near the End of Life in Patients With Gynaecologic Cancers. J Obstet Gynaecol Can 2021; 43: 26–33. [PMID: 32967796 DOI: 10.1016/j.jogc.2020.06.017] Patel A, Gupta VG, Biswas B, Das CK, Batra A, Ganguly S, Bhethanabhotla S. Revisiting Fulvestrant Dosing in Uncertain Economic Times. JCO Glob Oncol 2021; 7: 1–3. [PMID: 33405958 DOI: 10.1200/GO.20.00362] Batra A. Platelet Normalized Serum Vascular Endothelial Growth Factor Levels in Progressive Pediatric Solid Malignancies. Indian Pediatr 2020; 57: 1188. Singh N, Al-Ruwaisan M, Batra A, Itani D, Ghatage P. Factors Affecting Overall Survival in Premenopausal Women With Uterine Leiomyosarcoma: A Retrospective Analysis With Long-Term Follow-Up. J Obstet Gynaecol Can 2020; 42: 1483–1488. [PMID: 32900677 DOI: 10.1016/j.jogc.2020.05.016] Batra A, Kong S, Cheung WY. Eligibility of Real-World Patients With Stage II and III Colon Cancer for Adjuvant Chemotherapy Trials. Clin Colorectal Cancer 2020; 19: e226–e234. [PMID: 32636076 DOI: 10.1016/j.clcc.2020.05.005] Batra A, Kong S, Cheung WY. Eligibility of real-world patients with metastatic breast cancer for clinical trials. Breast 2020; 54: 171–178. [PMID: 33120082 DOI: 10.1016/j.breast.2020.10.005] Batra A, Hannouf MB, Alsafar N, Lupichuk S. Four cycles of docetaxel and cyclophosphamide as adjuvant chemotherapy in node negative breast cancer: A real-world study. Breast 2020; 54: 1–7. [PMID: 32861882 DOI: 10.1016/j.breast.2020.08.002] Batra A, Sheka D, Kong S, Cheung WY. Impact of pre-existing cardiovascular disease on treatment patterns and survival outcomes in patients with lung cancer. BMC Cancer 2020; 20: 1004. [PMID: 33059611 DOI: 10.1186/s12885-020-07487-9] Vanidassane I, Dhamija E, Naik SS, Batra A. An unusual durable response with palbociclib plus letrozole in hormone receptor positive metastatic breast cancer after multiple lines of therapy. Indian J Cancer 2020; 57: 348–350. [PMID: 32769294 DOI: 10.4103/ijc.IJC_66_19] Ding PQ, Batra A, Xu Y, McKinnon GP, Cheung WY. Obesity and Its Impact on Outcomes in Patients With Stage III Colon Cancer Receiving Adjuvant Chemotherapy. Clin Colorectal Cancer 2020; 19: 209–218. [PMID: 32291245 DOI: 10.1016/j.clcc.2020.02.010] Bosma NA, Tilley D, Batra A, Cheung WY. Characterizing Urban-Rural Differences in Colon Cancer Outcomes: A Population-based Analysis Based on Travel Distance to Cancer Center. Am J Clin Oncol 2020; 43: 531–535. [PMID: 32324599 DOI: 10.1097/COC.0000000000000703] Batra A, Rigo R, Sheka D, Cheung WY. Real-world evidence on adjuvant chemotherapy in older adults with stage II/III colon cancer. World J Gastrointest Oncol 2020; 12: 604–618. [PMID: 32699576 DOI: 10.4251/wjgo.v12.i6.604] Vanidassane I, Naik RD, Sharma V, Khurana S, Batra A. Adjuvant trastuzumab emtansine in human epidermal growth factor receptor 2-positive breast cancer: Take-home points from the KATHERINE trial. Natl Med J India 2020; 33: 158–159. [PMID: 33904420 DOI: 10.4103/0970-258X.314006] Patel A, Tannock IF, Srivastava P, Biswas B, Gupta VG, Batra A, Bhethanabhotla S, Pramanik R, Mahindru S, Tilak T, Das CK, Mehta P. Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets. JCO Glob Oncol 2020; 6: 382–386. [PMID: 32125899 DOI: 10.1200/JGO.19.00341] Baa AK, Naik RD, Vanidassane I, Arora S, Shamim SA, Mallick S, Batra A. Unusual Gastric Metastasis in Triple-Negative (Estrogen Receptor/Progesterone Receptor/HER2neu Negative) GATA-Binding Protein 3-Positive Breast Cancer. Indian J Nucl Med 2020; 35: 82–83. [PMID: 31949382 DOI: 10.4103/ijnm.IJNM_156_19] Mian A, Kumari K, Kaushal S, Fazal F, Kodan P, Batra A, Kumar P, Baitha U, Jorwal P, Soneja M, Sharma MC, Biswas A. Fatal familial hemophagocytic lymphohistiocytosis with perforin gene (PRF1) mutation and EBV-associated T-cell lymphoproliferative disorder of the thyroid. Autops Case Rep 2019; 9: e2019101. [PMID: 31440481 DOI: 10.4322/acr.2019.101] Mittal A, Batra A. Adjuvant chemotherapy in early breast cancer: Are we over-treating patients? Natl Med J India 2019; 32: 230–231. [PMID: 32769244 DOI: 10.4103/0970-258X.291305] Batra A, Patel A, Gupta VG, Mehta P, Tvsvgk T, Biswas B, Pramanik R, Das CK, Srivastava P. Oncotype DX: Where Does It Stand in India? J Glob Oncol 2019; 5: 1–2. [PMID: 31310569 DOI: 10.1200/JGO.19.00151] Vanidassane I, Sharma V, Ramteke P, Yadav MK, Batra A. Primary Yolk Sac Tumor of the Liver in an Adult Man. ACG Case Rep J 2019; 6: e00050. [PMID: 31616734 DOI: 10.14309/crj.0000000000000050] Naik RD, Batra A, Gupta VG. Palbociclib and Fulvestrant in Breast Cancer. N Engl J Med 2019; 380: 796. [PMID: 30786199 DOI: 10.1056/NEJMc1816595] Patekar M, Adhikari N, Biswas A, Raina V, Kumar L, Mohanti BK, Gogia A, Sharma A, Batra A, Bakhshi S, Garg A, Thulkar S, Sharma MC, Vishnubhatla S, Baghmar S, Sahoo RK. Primary CNS Lymphoma in India: A 17-Year Experience From the All India Institute of Medical Sciences. J Glob Oncol 2019; 5: 1–9. [PMID: 30811305 DOI: 10.1200/JGO.18.00124] Vanidassane I, Mittal A, Kumar C, Tanwar P, Sahoo RK, Batra A. Skin metastasis: a rare presentation in testicular germ cell tumour. BMJ Case Rep 2018; 2018. [PMID: 30249738 DOI: 10.1136/bcr-2018-226385] Biswas B, Ganguly S, Ghosh J, Batra A. Cisplatin-induced hearing loss in children with cancer. Natl Med J India 2017; 30: 327–328. [PMID: 30117444 DOI: 10.4103/0970-258X.239073] Pramanik R, Agarwala S, Gupta YK, Thulkar S, Vishnubhatla S, Batra A, Dhawan D, Bakhshi S. Metronomic Chemotherapy vs Best Supportive Care in Progressive Pediatric Solid Malignant Tumors: A Randomized Clinical Trial. JAMA Oncol 2017; 3: 1222–1227. [PMID: 28384657 DOI: 10.1001/jamaoncol.2017.0324] Srivastava R, Batra A, Dhawan D, Bakhshi S. Association of energy intake and expenditure with obesity: A cross-sectional study of 150 pediatric patients following treatment for leukemia. Pediatr Hematol Oncol 2017; 34: 29–35. [PMID: 28287332 DOI: 10.1080/08880018.2016.1272025] Batra A, Kashyap S, Singh L, Bakhshi S. Expression of FOXO3a and Correlation With Histopathologic Features in Retinoblastoma. Appl Immunohistochem Mol Morphol 2017; 25: 95–99. [PMID: 26574636 DOI: 10.1097/PAI.0000000000000278] Biswas B, Rastogi S, Batra A, Ganguly S. Trastuzumab and lapatinib in HER2-positive metastatic colorectal cancer. Natl Med J India 2016; 29: 219–220. Dabas A, Batra A, Khadgawat R, Jyotsna VP, Bakhshi S. Growth and Endocrinal Abnormalities in Pediatric Langerhans Cell Histiocytosis. Indian J Pediatr 2016; 83: 657–660. [PMID: 26988579 DOI: 10.1007/s12098-016-2053-y] Batra A, Kain R, Kumari M, Paul R, Dhawan D, Bakhshi S. Parents’ Perspective of Quality of Life of Retinoblastoma Survivors. Pediatr Blood Cancer 2016; 63: 1287–1289. [PMID: 27038275 DOI: 10.1002/pbc.25982] Batra A, Kumari M, Paul R, Patekar M, Dhawan D, Bakhshi S. Quality of Life Assessment in Retinoblastoma: A Cross-Sectional Study of 122 Survivors from India. Pediatr Blood Cancer 2016; 63: 313–317. [PMID: 26488435 DOI: 10.1002/pbc.25781] Batra A, Kashyap S, Singh L, Bakhshi S. Sirtuin1 Expression and Correlation with Histopathological Features in Retinoblastoma. Ocul Oncol Pathol 2015; 2: 86–90. [PMID: 27172132 DOI: 10.1159/000439594] Nataraj V, Batra A, Rastogi S, Khan SA, Sharma MC, Vishnubhatla S, Bakhshi S. Developing a prognostic model for patients with localized osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate: A single-center experience of 237 patients. J Surg Oncol 2015; 112: 662–668. [PMID: 26381138 DOI: 10.1002/jso.24045] Batra A, Thakar A, Bakhshi S. Ototoxicity in retinoblastoma survivors treated with carboplatin based chemotherapy: A cross-sectional study of 116 patients. Pediatr Blood Cancer 2015; 62: 2060. [PMID: 26053139 DOI: 10.1002/pbc.25618] Bakhshi S, Batra A, Biswas B, Dhawan D, Paul R, Sreenivas V. Aprepitant as an add-on therapy in children receiving highly emetogenic chemotherapy: a randomized, double-blind, placebo-controlled trial. Support Care Cancer 2015; 23: 3229–3237. [PMID: 25851802 DOI: 10.1007/s00520-015-2714-9] Batra A, Bakhshi S. Aprepitant for paediatric chemotherapy-induced nausea and vomiting. Lancet Oncol 2015; 16: e259-260. [PMID: 26065606 DOI: 10.1016/S1470-2045(15)70244-5] Singh N, Tripathi R, Mala Y, Batra A. Diagnostic Dilemma in Cornual Pregnancy- 3D Ultrasonography may Aid!! J Clin Diagn Res 2015; 9: QD12-13. [PMID: 25738045 DOI: 10.7860/JCDR/2015/6775.5484] Kumar L, Iqbal N, Mookerjee A, Verma RK, Sharma OD, Batra A, Pramanik R, Gupta R. Complete response after autologous stem cell transplant in multiple myeloma. Cancer Med 2014; 3: 939–946. [PMID: 24777883 DOI: 10.1002/cam4.257] Batra A, Pushker N, Venkatesh P, Arora T, Tewari R, Bakhshi S. Long-term visual outcomes in intraocular retinoblastoma with eye preservation. Clin Transl Oncol 2016; 18: 1034–1038. [PMID: 26781471 DOI: 10.1007/s12094-016-1482-4] Batra A, Patekar M, Bakhshi S. Short stature in retinoblastoma survivors: a cross-sectional study of 138 patients. Clin Transl Oncol 2016; 18: 381–384. [PMID: 26286069 DOI: 10.1007/s12094-015-1380-1] Singh N, Tripathi R, Tyagi S, Batra A. Antepartum fetal bladder rupture leading to urinary ascitis: attempt to rescue by placement of peritoneo-amniotic shunt. BMJ Case Rep 2013; 2013. [PMID: 23946514 DOI: 10.1136/bcr-2013-200021] Singh N, Tripathi R, Mala YM, Dixit R, Tyagi S, Batra A. Comparison of scar thickness measurements using trans-vaginal sonography and MRI in cases of pregnancy with previous caesarean section. Do they correlate with actual scar thickness? Journal of Obstetrics and Gynaecology 2013; 33: 810–813. [PMID: 24219719 DOI: 10.3109/01443615.2013.823926] Soneja M, Batra A, Vikram NK, Ahuja A, Mohan A, Sood R. Actinomycosis and nocardiosis co-infection in chronic granulomatous disease. J Assoc Physicians India 2012; 60: 66–68. Gupta S, Singh S, Sarkar S, Batra A. Development and validation of the ethical challenges in clinical situations-questionnaire (ECCS-Q) by involving health-care providers from a tertiary care health setting. Clinical Ethics. April 2021. doi:10.1177/14777509211011427 Dabkara D, Ganguly S, Ghosh J, Patel A, Batra A, Das CK, et al. How We Treat Genitourinary Cancers During COVID-19 Pandemic? 1 2020;5:147–52. https://doi.org/10.31557/apjcc.2020.5.S1.147-152. Ghosh J, Ganguly S, Biswas B, Dabkara D, Srivastava P, Patel A, et al. Systemic treatment of gastroesophageal cancer during SARS-CoV2. Indian Journal of Medical and Paediatric Oncology 2020;41:141. https://doi.org/10.4103/ijmpo.ijmpo_118_20. Bhethanabhotla S, Pramanik R, Srivastava P, Mehta P, Patel A, Biswas B, et al. Colorectal cancer chemotherapy during COVID-19 pandemic. Indian Journal of Medical and Paediatric Oncology 2020;41:156. https://doi.org/10.4103/ijmpo.ijmpo_149_20. Pramanik R, Srivastava P, Sharma A, Mehta P, Patel A, Bhethanbhotla S, et al. Management of head-and-neck cancer during COVID-19 crisis: A medical oncology perspective. Indian Journal of Medical and Paediatric Oncology 2020;41:153. https://doi.org/10.4103/ijmpo.ijmpo_134_20. Mahindru S, Das CK, Patel A, Mehta P, Biswas B, Batra A, et al. Cancer surgery in challenging time of COVID-19 pandemic – A pragmatic approach. Indian Journal of Medical and Paediatric Oncology 2020;41:144. https://doi.org/10.4103/ijmpo.ijmpo_121_20. Das CK, Mahindru S, Patel A, Batra A, Biswas B, Mehta P, et al. How I treat epithelial ovarian cancer during COVID-19 pandemic. Indian Journal of Medical and Paediatric Oncology 2020;41:138. https://doi.org/10.4103/ijmpo.ijmpo_112_20. Batra A, Mehta P, Patel A, Bhethanabhotla S, Biswas B, Pramanik R, et al. Breast cancer treatment during the COVID-19 pandemic. Indian Journal of Medical and Paediatric Oncology 2020;41:135. https://doi.org/10.4103/ijmpo.ijmpo_111_20. Patel A, Batra A, Mehta P, Sharma A, Sirohi B, Biswas B, et al. Gallbladder cancer: Adjuvant and palliative treatment during Covid-19 pandemic in India. Indian Journal of Medical and Paediatric Oncology 2020;41:132. https://doi.org/10.4103/ijmpo.ijmpo_110_20. Biswas B, Ganguly S, Dabkara D, Ghosh J, Srivastava P, Mehta P, et al. How we treat lung cancer during SARS-Cov-2 (COVID-19) pandemic in India? Indian Journal of Medical and Paediatric Oncology 2020;41:149. https://doi.org/10.4103/ijmpo.ijmpo_122_20. Mehta P, Parikh P, Aggarwal S, Batra A, Patel A, Kulkarni P, et al. Has India met this enemy before? From an eternal optimist’s perspective: SARS-CoV-2. IJMS 2020;72:8–12. https://doi.org/10.25259/IJMS_30_2020. Parikh P, Mehta P, Bansal S, Aggarwal S, Patel A, Batra A, et al. Protecting health-care professionals and workers (other than COVID-19 management facilities) from contamination during COVID-19 pandemic (March 26, 2020 – India). IJMS 2020;72:3–4. https://doi.org/10.25259/IJMS_28_2020. Sharma A, Mittal A, Barwad A, Mridha AR, Venkatesan S, Sahoo RK, et al. Recurrent germ cell tumour presenting as fractured neck of the femur: Journal of Clinical Urology 2019. https://doi.org/10.1177/2051415819841964. Pushpam D, Raj A, Batra A, Bakhshi S. Occam’s razor versus Hickam’s dictum: An unusual cause of acute renal failure in pediatric solid malignancy. Indian Journal of Medical and Paediatric Oncology 2019;40:445. https://doi.org/10.4103/ijmpo.ijmpo_54_18. Patel A, Tilak TV, Gupta VG, Batra A, Mehta P, Parikh P, et al. Dynamics of sequencing of cyclin-dependent kinase inhibitors and cost expenditure analysis in the management of metastatic hormone-receptor positive, human epidermal growth factor 2-negative advanced breast cancer. Indian Journal of Medical and Paediatric Oncology 2019;40:311. https://doi.org/10.4103/ijmpo.ijmpo_111_19. Mehta P, Batra A, Patel A. Commentary on oncotype Dx. Indian Journal of Medical and Paediatric Oncology 2019;40:434. https://doi.org/10.4103/ijmpo.ijmpo_226_19. Pramanik R, Kancharla H, Bakhshi S, Sharma A, Gogia A, Malik P, Sahoo RK, Batra A, Thulkar S, Kumar L. Engraftment Syndrome: A Retrospective Analysis of the Experience at a Tertiary Care Institute. Clinical Hematology International 2019; 1: 114–119. [DOI: 10.2991/chi.d.190504.001] ABSTRACTS Batra A, Kong S, Rigo R, Cheung WY. Impact of preexisting cardiovascular disease (CVD) on treatments and outcomes of patients with breast or lung cancer. JCO. 2020;38(15_suppl):12063-12063. doi:10.1200/JCO.2020.38.15_suppl.12063 Batra A, Cuthbert CA, Harper A, et al. Impact of baseline symptom burden as assessed by patient-reported outcomes (PROs) on overall survival (OS) of patients with metastatic cancer. JCO. 2020;38(15_suppl):12020-12020. doi:10.1200/JCO.2020.38.15_suppl.12020 Batra A, Kong S, Rigo R, Cheung W. 150P Eligibility of real-world patients with metastatic breast cancer in clinical trials. Annals of Oncology. 2020;31:S70. doi:10.1016/j.annonc.2020.03.250 Batra A, Cuthbert C, Rigo R, et al. 187P Patient-reported outcomes near end-of-life in patients with breast cancer. Annals of Oncology. 2020;31:S84. doi:10.1016/j.annonc.2020.03.126 Rigo R, Koczka K, Batra A, Cheung WY, Monzon JG, Cheng T. Adjuvant systemic therapies for melanoma in Alberta: An early descriptive analysis of population characteristics and treatment outcomes. JCO. 2020;38(15_suppl):e22013-e22013. doi:10.1200/JCO.2020.38.15_suppl.e22013 Peng J, Batra A, Cheung WY. Referral-to-treatment attrition and its impact on outcomes of patients with advanced gastroesophageal cancers. JCO. 2020;38(15_suppl):e16504-e16504. doi:10.1200/JCO.2020.38.15_suppl.e16504 Cheung WY, Rigo R, Batra A. Use of Twitter among cancer clinicians and researchers and the associations with scientific impact of its users and followers. JCO. 2020;38(15_suppl):e14101-e14101. doi:10.1200/JCO.2020.38.15_suppl.e14101 Batra A, Kong S, Cheung WY. Eligibility of real-world patients with stage II/III colorectal cancer (CRC) in adjuvant chemotherapy (AC) trials. JCO 2020;38:50–50 [DOI: 10.1200/JCO.2020.38.4_suppl.50] Batra A, Cheung WY, Tang PA. Real-world eligibility of advanced pancreatic (APC) patients for maintenance olaparib. JCO 2020;38:653–653 [DOI: 10.1200/JCO.2020.38.4_suppl.653] Mayank Singh, Atul Batra, Sameer Bakhshi, Matthew Summers. Validation of Ubiquitin specific peptidases 37 as a prognostic and diagnostic marker in osteosarcoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 1256. Batra A, Dhawan D, Paul R, Kumari M, Bakhshi S.Improvement in Compliance of Patients with Non-Metastatic Retinoblastoma with Low-Cost Prospective Database and Patient Tracking System: A Study from Tertiary Care Centre in India. Pediatric Blood & Cancer. Volume 64, Issue S3, November 2017. Version of Record online : 1 Sep 2017, doi: 10.1002/pbc.26772 Biswas B, Jha A, Batra A, Sengupta M, Bakhshi S. Pretreatment neutrophilto lynphocyte ratio in ewing sarcoma family of tumors: An analysis of 570 patients. JCO 2017;35:e22504–e22504 [DOI: 10.1200/JCO.2017.35.15_suppl.e22504] Pramanik R, Batra A, Agarwala S, Gupta YK, Thulkar S, Vishnubhatla S, Dhawan D, Bakhshi S. Progressive Paediatric Solid Tumours other than Bone-Sarcomas Benefit from Metronomic Chemotherapy: A Subgroup Analysis from a Double Blind Placebo Controlled Randomized Study. SIOP 2016 Scientific Programme+Index. Pediatr Blood Cancer, 63: S5–S321.doi:10.1002/pbc.26233. Batra A, Bakhshi S, Pushker N.Prognostic Factors in Metastatic Retinoblastoma: A Study of 70 Metastatic Retinoblastoma Patients Treated at a Single Centre in India. SIOP 2016 Scientific Programme+Index. Pediatr Blood Cancer, 63: S5–S321. doi:10.1002/pbc.26233. Batra A, Kashyap S, Pushker N, Meel R, Bakhshi S. Retinoblastoma in Children Older Than 6 Years: A Single Centre Study of 58 Patients from India. SIOP 2016 Scientific Programme+Index. Pediatr Blood Cancer, 63: S5–S321. doi:10.1002/pbc.26233. Batra A, Pushker N, Venkatesh N, Arora T, Tewari R, Bakhshi S. Correlation of Quality of Life and Visual Acuity in Survivors of Bilateral Retinoblastoma Managed with Enucleation of One Eye and Salvage of Other Eye. Support Care Cancer (2016) 24(Suppl 1): 1. https://doi.org/10.1007/s00520-016-3209-z. Pramanik R, Bakhshi S, Agarwala S, Gupta YK, Thulkar S, Vishnubhatla S, Batra A, Dhawan D. Metronomic therapy versus best supportive care in progressive pediatric solid malignancies: A double blind placebo controlled randomized study. JCO 2016;34:10520–10520 [DOI: 10.1200/JCO.2016.34.15_suppl.10520] Batra A, Kumari M, Paul R, Dhawan D , Bakhshi S. Quality of life in retinoblastoma: Quality of life assessment in retinoblastoma: A cross-sectional study of 122 survivors.10.1200/jco.2015.33.15_suppl.10068 Journal of Clinical Oncology 33, no. 15_suppl (May 2015) 10068-10068. Batra A, Pushker N, Venkatesh N, Bakhshi S. Visual outcomes and ocular coherence tomography in patients with intraocular retinoblastoma with eye preservation. Annals of Oncology, Volume 26, Issue suppl_9, 1 December 2015, Pages ix156, https://doi.org/10.1093/annonc/mdv535.02. Bakhshi S, Batra A, Kumari M, Paul R, Patekar M, Dhawan D. Parents’ Perspective Of Quality Of Life In Retinoblastoma Survivors: A Cross-Sectional Study Of 122 Patients. SIOP 2015 Scientific Programme + Index. Pediatr Blood Cancer, 62: S143–S418. doi:10.1002/pbc.25715. Batra A, Kashyap S, Singh L, Bakhshi S. Cytoplasmic Expression of Foxo3a in Retinoblastoma Predicts High Risk Histopathological Features. A Cross-Sectional Study Of 122 Patients. SIOP 2015 Scientific Programme + Index. Pediatr Blood Cancer, 62: S143–S418. doi:10.1002/pbc.25715. Batra A, Kashyap S, Singh L, Bakhshi S. Sirtuin1 Expression and Correlation with Histopathological Features In Retinoblastoma. SIOP 2015 Scientific Programme + Index. Pediatr Blood Cancer, 62: S143–S418. doi:10.1002/pbc.25715. Batra A, Thakar A, Patekar M, Bakhshi S. Long-term non-visual outcomes in retinoblastoma survivors SIOP 2015 Scientific Programme + Index. Pediatr Blood Cancer, 62: S143–S418. doi:10.1002/pbc.25715. Batra A, Shrivastava R, Tyagi A , Dhawan D, Ramakrishnan L, Bakhshi S. An Insight Into The Biomarkers Of Obesity In Survivors Of Acute Leukemia. 46th Congress of the International Society of Paediatric Oncology (SIOP) 2014. Pediatr Blood Cancer, 61: S105–S433. doi:10.1002/pbc.25314. Bakhshi S, Batra A, Biswas B, Dhawan D, Paul R, Sreenivas V. Aprepitant As An Add-On Therapy In Children Receiving Highly Emetogenic Chemotherapy: A Randomized, Double Blind, Placebo-Controlled Trial. 46th Congress of the International Society of Paediatric Oncology (SIOP) 2014. Pediatr Blood Cancer, 61: S105–S433. doi:10.1002/pbc.25314.   Presentations Year Conference/Venue Abstract(s) Presentation (Award) 2020 ESMO Annual Congress   i. Association of pre-existing cardiovascular disease (CVD) in older patients with breast cancer with treatment and survival outcomes  ii. Determinants of new onset cardiovascular disease (CVD) in cancer patients  Mini-oral    E-Poster 2020 ESMO World Congress on Gastrointestinal cancers     Barcelona, Spain    Impact of baseline symptom burden as assessed by patient-reported outcomes (PROs) on overall survival (OS) of patients with metastatic gastrointestinal (GI) cancer Patient-reported outcomes in patients with gastric and esophageal cancers near end-of-life Poster discussion   (Young Investigator Award) Poster 2020 ASCO Annual meeting 2020, Chicago, USA     Impact of preexisting cardiovascular disease (CVD) on treatments and outcomes of patients with breast or lung cancer. Impact of baseline symptom burden as assessed by patient-reported outcomes (PROs) on overall survival (OS) of patients with metastatic cancer. Poster      (ASCO Merit Award) Poster discussion 2020 ESMO Breast 2020, Berlin, Germany     Patient-reported outcomes near end-of-life in patients with breast cancer  Eligibility of real-world patients with metastatic breast cancer in clinical trials    Poster   Poster (Merit Award)   2020 Multinational Association of Supportive Care in Cancer (MASCC) Annual Meeting, Seville, Spain (Accepted, to be presented) Impact of pre-existing cardiovascular disease on treatment patterns and outcomes in patients with lung cancer Physical and psychological symptom burden near end of life in patients with lung cancer using patient-reported outcomes Eposter    Eposter 2020 Canadian Association of Medical Oncology (CAMO) Annual Meeting, Toronto, Canada(Accepted, to be presented) Eligibility of real-world patients with stage II/III colorectal cancer in adjuvant chemotherapy trials   Oral 2020 American Society of Clinical Oncology (ASCO) GI Symposium, San Francisco, USA Eligibility of real-world patients with stage II/III colorectal cancer in adjuvant chemotherapy trials. Real-world eligibility of advanced pancreatic patients for maintenance olaparib Poster    Poster 2017 International Society of Paediatric Oncology (SIOP) Annual Meeting, Washington DC, USA Improvement in compliance of patients with non-metastatic retinoblastoma with low-cost prospective database and patient tracking system: a study from tertiary care centre in India. Oral, Young Investigator Award 2016 SIOP Annual Meeting, Dublin, Ireland Prognostic factors in metastatic retinoblastoma: a study of 70 metastatic retinoblastoma patients treated at a single centre in India Retinoblastoma in children older than 6 years: a single centre study of 58 patients from India E-poster         2016 MASCC, Adelaide, Australia Correlation of quality of life and visual acuity in survivors of bilateral retinoblastoma managed with enucleation of one eye and salvage of other eye Oral, Travel Scholarship Award 2015 ASCO Annual Meeting, Chicago, USA Quality of life assessment in retinoblastoma: a cross-sectional study of 122 survivors. Poster, ICMR Travel Award 2015 ESMO Asia, Singapore Visual outcomes and ocular coherence tomography in patients with intraocular retinoblastoma with eye preservation. Poster ESMO Travel Award 2015 SIOP Annual Meeting, Capetown, South Africa Long-term non-visual outcomes in retinoblastoma survivors Expression of Foxo3a in Retinoblastoma Predicts High Risk Histopathological Features. A Cross-Sectional Study Of 122 Patients. Sirtuin1 Expression and Correlation with Histopathological Features In Retinoblastoma. Oral Young Investigator Award E-poster    E-poster 2014 SIOP Annual Meeting, Toronto, Canada An insight into the biomarkers of obesity in survivors of acute leukaemia. Poster

 

 

 

 

 

 

 

 

 

 

 

S.No	Names	Month & Year of PhD Awarded
1	Dr. Gottemukkala Muralik Raju	February-1999
2	Dr. Ashutosh Pathak	May-2002
3	Dr. Pratibha Sharma	January-2010
4	Dr. Rashmi Bhardwaj	September-2010
5	Dr. Rakesh Verma	March-2011
6	Dr. Nitin Mathur	February-2012
7	Dr. Surender Kumar Sharawat	May-2013
8	Dr. Nivedita Pathak	September-2013
9	Dr. Minakshi Mann	February 2014 – July 2020
10	Dr. Anudishi Tyagi	January 2013 - February 2019
11	Dr. Shivali Jasrotia	August 2011 - July 2019
12	Dr. Mohsin Maqbool	February 2010 - December 2018
13	Dr. Shilpi Chaudhary	February 2016- October 2021
14	Dr. Anjali Mookerjee	February 2015 - December 2021
15	Dr. Luxmi Devi	February 2015- February 2022

Dr Lalit Kumar, MD; DM

Professor and Head

Department of Medical Oncology

All India Institute of Medical sciences

(Dr BRA Institute Rotary Cancer Hospital)

New Delhi 110029, India

E-Mail:   medoncoaiims@gmail.com

 

 

Research Interests

• Blood stem cell /Bone marrow transplantation
• Hematological malignancies, (Multiple myeloma , chronic myeloid leukaemia, Infections)
• Gynaecological malignancies: Role of neo-adjuvant Chemotherapy

 

Name–Dr. Raja Pramanik  

Qualification: MD (Internal Medicine), DM (Medical Oncology) 

Designation- Assistant Professor, Department of Medical Oncology

Address- Room No. 216, Department of Medical Oncology, 2^nd Floor, Dr B.R.A-I.R.C.H ,AIIMS , Ansari Nagar, New Delhi 110029 

Contact Info :Email – drrajapramanik@gmail.com  

Academic Career – Dr. Raja Pramanik graduated from the R.G.Kar Medical College of Calcutta University and received his MD degree in Internal Medicine from Patna Medical College, Patna University. He did his senior resident ship in Medical oncology at theDr. B. R. A- IRCH,  AIIMS, New Delhi and completed his DM degree in Medical Oncology from AIIIMS. He was recruited as a faculty in Medical Oncology at the Dr. B R A –IRCH, AIIMS, New Delhi in 2016. Caring for cancer patients, research to improve their care and clinical teaching are his greatest passions. 

Area of Expertise- Dr.Pramanik is a member of the multidisciplinary teams at Dr. B.R.A-IRCH taking care of the Gastro-intestinal cancers (e.g. cancers in the esophagus, stomach, liver, gall bladder, Colon and rectum) and Head and Neck cancers and routinely takes care of these patients in the OPD and wards. He also has keen interest in Clinical Cancer genetics, genetic counselling and research. He also actively participates in clinical services for adult haematological malignancies e.g. Hodgkins lymphoma, NHL, Acute and Chronic Leukemias and Multiple myeloma. 

Research Interests:Esophageal cancer, Clinical Cancer genetics, immuno-oncology, Translational oncology, Metronomic chemotherapy. 

Awards-

1.            Received the prestigious “Brigid Leventhal Merit Award” in June 2016 at the Annual meeting of American Society of Clinical Oncology(ASCO), in Chicago for the best abstract in Paediatric Oncology by a fellow, as determined by the Program

               Committee's   Paediatrics Subcommittee.

2.            Received IDEA Award (International Development and Education Award) 2016 from American Society of Clinical Oncology, in Chicago, June 2016.

3.            Received “Young oncologists Investigator Award” (YIA) from the International Society of Paediatric Oncology (SIOP) for the year 2016. (Annual Meeting, Dublin, Ireland).

4.            Received Travel Grant from ESMO (European Society for Medical Oncology) to  attendESMO Academy-2016, at Oxford, United Kingdom in August 2016.

5.            Received the“ESMO–Image of the year Award” 2015 from European Society for Medical Oncology.

6.            Received Travel grant from Department of Science & Technology to attend the 15th International Myeloma Workshop in Rome, Sept 2015. (presented two posters on Engraftment syndrome and POEMS syndrome)

7.            Indian Society for Medical and Paediatric Oncology (ISMPO) Gold medal exam 2016, Chennai: 2nd runner-up prize.

8.            Received Travel Grant from European Society for Medical Oncology (ESMO) to attend ESMO Asia Conference in Singapore in December 2015.

9.            Received Travel Grant from European Society for Medical Oncology (ESMO) to attend Preceptorship meet in Gastric Cancer in August 2015 in Brussels, Belgium.

10.          Honours in Anatomy, Physiology, Pharmacology, Preventive & Social Medicine, (MBBS)

11.          Gold medal in ENT, Preventive & Social Medicine(MBBS) 

 

Membership of Professional bodies:

1.            Member: European Society for Medical Oncology, (ESMO).

2.            Member: American Society of Clinical Oncology, (ASCO).

3.            Member: Indian Society of Medical and Paediatric Oncology,(ISMPO)

4.            Member: Paediatric Hemato-Oncology chapter of Inadian Academy of Paediatrics (PHO-IAP) 

 

Selected Publications:       

1.      Pramanik R, Agarwala S, Gupta Y K, Bakhshi S; et al. Metronomic Chemotherapy vs Best Supportive Care in Progressive Pediatric Solid Malignant Tumors: A Randomized Clinical Trial JAMA Oncol. Published online April 6, 2017.    doi:10.1001/jamaoncol.2017.0324

2.      Pramanik R, Kumar L. 302PEngraftment syndrome during hematopoietic stem cell transplant: Analysis of 166 transplants from a tertiary care centre. Ann Oncol. 2015 Dec 1;26(suppl 9):ix89–ix89.

3.      Pramanik R, Kumar L. Engraftment Syndrome During Auto HSCT in Plasma Cell Disorders: Retrospective Analysis of Consecutive Cases From a Tertiary Care Centre. Clin Lymphoma Myeloma Leuk. 2015 Sep 1;15:e159–60.

4.      Pramanik R, Kumar L, Cyriac SL. Poems Syndrome: A Retrospective Analysis of Clinicopathological Profile and Treatment Outcomes of 43 Consecutive Cases from a Tertiary Cancer Centre in India. Clin Lymphoma Myeloma Leuk. 2015 Sep 1;15:e198–9.

5.      Pramanik R, Gogia A, Sahoo RK. Manuscript entitled “Neutropenia due to Palbociclib : a word of caution”, with manuscript number ijmpo_158_15, is accepted for publication in the Indian Journal of Medical and paediatric Oncology, IJMPO”(July-Sept 2016 issue)

6.      Kumar L, Iqbal N, Mookerjee A, Verma RK, Sharma OD, Batra A, et al. Complete response after autologous stem cell transplant in multiple myeloma. Cancer Med. 2014 Aug;3(4):939–46.

7.      Kumar L, Pramanik R, Kumar S, Bhatla N, Malik S. Neoadjuvant chemotherapy in gynaecological cancers – Implications for staging. Best Pract Res ClinObstetGynaecol. 2015 Aug 1;29(6):790–801.

8.     Gogia A, Khurana S, Paramanik R. Acute Myocardial Infarction after First Dose of Rituximab Infusion. Turk J Hematol. 2014 Mar;31(1):95–6.

9.      Gogia A, Mehta P, Pramanik R, Gupta R .Chronic lymphocytic leukemia with massiveascites: An unusual presenting manifestation. South Asian J Cancer. 2014 Oct-Dec;3(4):235-236 PMID:25422818

10.    Vallonthaiel AG, Kaur K, Jain D, Singh G, Tiwari D, Pramanik R, et al. Ewing Sarcoma of Urinary Bladder Showing EWSR1 Rearrangement on FISH Analysis and Unique Response to Chemotherapy. ClinGenitourinCancer , 2016 Apr;14(2):e183-6. doi:10.1016/j.clgc.2015.11.001. Epub 2015 Nov 11. PMID:266848127.

11.    Image of the Month: November 2015 | Oncology Diagnosis Project | ESMO [Internet]. [cited 2015 Dec 2]. Available from: http://www.esmo.org/Career-Development/Young-Oncologists-Corner/Image-of-the-Month/November-2015-Image-of-the-Month

12.    Ranjan A, PramanikR,Gupta R, Tanwar P, Bharti S et al ;Chronic Neutrophilic Leukemia: A Rare Chronic Myeloproliferative Disorder. International Journal of Hematology and Oncology 2014, Vol 24, Num 2 Page(s): 145-147       

13.    Gahlot GP, Mridha AR, Sable M, Sharma MC, Pramanik R, Kumar L.Solidpseudopapillary  neoplasm of the ovary with metastases to the omentum and regional lymph nodes.IndianJPatholMicrobiol. 2016 Jul-Sep;59 (3):348-50. doi: 10.4103/0377- 4929.188107.PMID:   27510674

14.    Gogia A, Mehta P, Pramanik R, Kumar .Isolated breast relapse mimicking breast cancer in elderly patient with acute lymphoblastic leukemia. R.Turk J Haematol. 2014 Jun;31(2):203-4. doi: 0.4274/tjh.2013.0270. Epub 2014 Jun 10. PMID:25035685

Curriculum Vitae

 

 

Ajay Gogia, MD, DM, is an  Professor in the Department of Medical Oncology at Dr. B.R.A Institute-Rotary Cancer Hospital All India Institute of Medical Sciences (AIIMS), New Delhi, India. He received his M.B.B.S, MD (Internal Medicine) degree from Banaras Hindu University, DM (Medical Oncology) from AIIMS, New Delhi. He has over 17 year of working and teaching experience in Medical Oncology and specializes in All variants of Breast Cancer, Non-Hodgkin’s Lymphoma,Chronic lymphocytic leukemia, Hodgkin Lymphoma and Multiple Myeloma. He has gained his International exposurein Europe,United states of America (USA), United Kingdom (UK) and Canada throughmultiple fellowships and honoured observerships.. His research is well published with more than 400 peer reviewed articles in National and International oncology journals and is well citedover thousand citations . His letters and correspondence are well accepted and published in reputed journalslike New England journal of Medicine (NEJM), Lancet Oncology, Journal of clinical oncology (JCO) and JAMA Oncology. He has received Dronacharya Award for his excellence by Health Minister ,Thrice Golden aim Award for teaching, patient care and research and best researcher award from Global forum of Artificial Intelligene and Robotics. He is actively involve in management of breast cancer in every aspects :prevention, screening, chemotherapy, hormonal therapy, targeted therapy and immuunotherapy

 

 

Name : Dr. Ajay Gogia

Qualifications : MBBS,

MD (Internal Medicine),

DM (Medical Oncology)

Current Appointment :  Professor

Department of Medical Oncology, Dr. B.R.A, I.R.C.H,

All India Institute of Medical Sciences (AIIMS)

Ansari Nagar, New Delhi, 110029

Nationality : Indian

 

Education and Qualifications

Degree	University	Year
MBBS	Institute of Medical Sciences, Banaras Hindu University, Varanasi-India	2000
M.D (Internal Medicine)	Institute of Medical Sciences, Banaras Hindu University, Varanasi-India	2003
D.M. (Medical Oncology)	All India Institute of Medical Sciences(AIIMS),New Delhi, India	2011

  

Working place and post

Post	University/ INSTITUTE	Year
Senior Residency and D.M ( Doctrate of medicine) ( Medical Oncology)	All India Institute of Medical Sciences(AIIMS), New Delhi, India	2006-11
SeniorResearch Associate (Pool Officer)	All India Institute of Medical Sciences(AIIMS), New Delhi, India	2011-12
Assistant Professor	All India Institute of Medical Sciences(AIIMS), New Delhi, India	2013- 2016
Associate Professor	All India Institute of Medical Sciences(AIIMS), New Delhi, India	2017- 2019
Additional Professor	All India Institute of Medical Sciences(AIIMS), New Delhi, India	2020-till date

 

Working&TEACHING experienec in medical oncology:17 years

Specific Area of Interest	OPD Schedule and timing	Member of the multidisciplinary teams of Breast cancer clinic (BCC) and lymphoma clinic at Dr. B.R.A-IRCH, All India Institute of Medical Sciences (AIIMS)and taking care of Medical Management of Breast cancer, B-cell Non Hodgkin lymphoma,Hodgkin Lymphoma, Multiple myeloma andChronic lymphocytic leukemia’s
Breast Cancer	Monday (2.00pm, Breast cancer clinic, Board Room).Wednesday (9.30 am), Adult Medical Oncology clinic, Board Room Friday (9.30 am ) Adult Medical Oncology clinic, Room No 1
Non-Hodgkin and Hodgkin Lymphoma,Chronic lymphocytic leukemia (CLL) and Multiple Myeloma	Thursday (9.30 am, Lymphoma and Myeloma clinic, Room No. 4), Wednesday and Friday (9.30 am, Adult Medical Oncology Clinic, Board Room)

 

Fellowship	PLACE	Year
Indian American cancer Association-(IACA) Fellowship	Cleveland Clinic. OHIO, United States of America (USA) Mentor: Prof. Jame Abraham	2016
European Society Of Medical Oncology (ESMO) Fellowship	Jules Bordet Hospital, Brussels Mentor: Prof. Martine Piccart	2017
MD Anderson Cancer center (MDACC) short term fellowship	MDACC, Houston, Texas,USA Mentor :Prof. Hagop M.Kantarjian / Prof. Jain	2018
ESMO- Palliative care fellowship	Princess Margaret Cancer CentreToronto,Canada Mentor : Prof. Subratha Banerjee	2019

 

Hounoured Observer- ship	PLACE	Year
ESO:Short term in-house observer ship	The Royal Marsden Hospital, London UK	2019
ASH: Short term in-house observer ship	Sarah Cannon Center, Nashville, USA	2017
MASTERCLASS and in house observership on BREAST CANCER	Memorial Sloan Kettering Cancer Center (MSK or MSKCC)	2023

 

Awards/Honors		Year
Dronacharya-Award-Excellence in Oncology	Received by Minister of Health and welfare	2019
Golden Aim Award -Teaching	Received by Minister of Health and welfare	2020
Golden Aim Award -Research	Received by President IMA	2021
Golden Aim Award _Patient care	Received by President IMA	2023
Hans WyderAward	Ascona, Switzerland	2013
Young Investigator Award	International Society of hematology and oncology (SOHO),Texas,USA	2022
Merit Award	Asco2011 ,Chicago,usa	2011
Young Investigator and Best Poster Award	Global Breast Cancer Conference, Seoul	2020
Young Investigator award	Gi-Esmo, Barcelona	2015
Travel scholarship and Best Poster Award	Esmo , Barcelona , Spain	2019
Young investigator award	Saint Gallen Breast Cancer Conference	2013

  

ESMO PRECEPTORSHIP Place Year
Colorectal Cancer	Prague	6-7 July 2016
Immuno-Oncology	Amsterdam,	30 September – 1 October 2015
Signalling Pathways	Barcelona	13 – 14 March 2015
Non-Small Cell Lung Cancer	Copenhagen	7-8 July 2015
GI Neuroendocrine tumors	Singapore	2-3 November 2012

  

International Oncology Research scholarship/grant	PLACE	Year
American Association of Cancer Research (AACR)/Australia & Asia Pacific Clinical Oncology Research Development (ACORD)	Sydney, Australia	2018
INDOX Cancer Research Network	University of Oxford, United Kingdom ( UK)	2012
European Society Of Medical Oncology (ESMO)- Translational unit visit	Christie NHS Foundation Trust, Manchester, United Kingdom ( UK)	2012
European School of Oncology –Master class in clinical Oncology	Ermatingen, Switzerland	2012

Miscellaneous

Principal Investigator: projects -3 ( active ) , total =9

DM ( Medical Oncology ) and DNB Examiner in different hospitalssince 2019

CLINICAL PROJECT – AS A CO- INVESIGATOR with Different super/sub specialties in AIIMS (40 in number)

Setting up Hospital Based Cancer Registries ( HBCRs) and Pattern of Care and Survival Studies on Breast Cancer

DM-Medical Oncology Teaching curriculum & Exam Coordinator: between 2013-2022

Expert member in Executice commetie of Ethics at Safderjang Hospital, New Delhi

Active participation in teaching including MBBS/MD/DM/ MSc Nursing Student

Active Participation in Annual Free Medical Camp organized by AIIMS and Govt. of India at LEH, DHARAMSHALA, Jhanskar,Tawang (Arunachal Pradesh) and MUNGDOD Hubli

Regular Participating in patient awareness programme in DOORDARSHAN, DD news & RAJSABHA TV

 

 CURRENT MEMBERSHIPS IN PROFESSIONAL SOCIETIES

• Members in American Society of Clinical Oncology-(ASCO ID -10476)

• European Society of Medical Oncology- ESMO-ID-(82716)

 

PUBLICATIONS: over 400(Name Highlighted)

• Yadav MP, Ballal S, Martin M, Roesch F, Satapathy S, Moon ES, Tripathi M, Gogia A.Bal C. Therapeutic potential of [¹⁷⁷Lu]Lu-DOTAGA-FAPi dimers in metastatic breast cancer patients with limited treatment options: efficacy and safety assessment. Eur J Nucl Med Mol Imaging. 2024 Feb;5 1(3):805-819. doi: 10.1007/s00259-023-06482-z. Epub 2023 Nov 7. PMID: 37932560.

• Chatzikonstantinou T, Scarfò L, Karakatsoulis G, Minga E, Chamou D, Iacoboni G, Kotaskova J, Demosthenous C, Smolej L, Mulligan S,Alcoceba M, Al-Shemari S, Aurran-Schleinitz T, Bacchiarri F, Bellido M, Bijou F, Calleja A, Medina A, Khan MA, Cassin R, Chatzileontiadou S, Collado R, Christian A, Davis Z, Dimou M, Donaldson D,Santos GD, Dreta B, Efstathopoulou M, El-Ashwah S, Enrico A,Fresa A, Galimberti S, Galitzia A, García-Serra R, Gimeno E, González-Gascón-Y-Marín I, Gozzetti A, Guarente V, Guieze R, Gogia A.et al .Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY. EClinicalMedicine. 2023 Nov 15; 65:102307.doi: 10.1016/j.eclinm.2023.102307. PMID: 38033506; PMCID: PMC10685149.

• Kumar R, Kumar R, Goel H, Kumar S, Ningombam SS, Haider I, Agrawal U, Deo S, Gogia A.Batra A, Sharma A, Mathur S, Ranjan A, Chopra A, Hussain S, Tanwar P. Whole exome sequencing identifies novel variants of PIK3CA and validation of hotspot mutation by droplet digital PCR in breast cancer among Indian population. Cancer Cell Int. 2023 Oct 11;23(1):236. doi: 10.1186/s12935-023-03075-6. PMID: 37821962; PMCID: PMC10568783.

• Sharma RK, Gogia A.Deo S, Sharma D, Mathur S, Sagiraju HKR. Dose-dense neoadjuvant chemotherapy in triple-negative breast cancer: Real-world data from a developing country. Indian J Cancer. 2023 Oct 1; 60(4):505-511.doi: 10.4103/ijc.ijc_1120_21. Epub 2024 Jan 4. PMID: 38189648.

• Paikaray SK, Gogia A.Kumar L, Sharma A, Biswas AA, Vishnubhatla S, Mallick S. A Phase III open-label randomized study to compare the efficacy of lenalidomide-rituximab with bendamustine-rituximab in treatment-naïve follicular lymphoma. Indian J Cancer. 2023 Oct 1; 60(4):501-504.doi: 10.4103/ijc.IJC_633_20. Epub 2024 Jan 4. PMID: 38185869.

• Kashyap A, Umar SM, Dev J R A, Mathur SR, Gogia A.Batra A, Deo SVS, Prasad CP. Combination of 3PO analog PFK15 and siPFKL efficiently suppresses the migration, colony formation ability, and PFK-1 activity of triple-negative breast cancers by reducing the glycolysis. J Cell Biochem. 2023 Sep;12 4(9):1259-1272. doi: 10.1002/jcb.30443. Epub 2023 Jul 14. PMID: 37450687.

• Sahu MK, Singh SP, Satsangi A, Gogia A.Hote MP, Seth S. Posttransplant lymphoproliferative disorder in a heart transplant recipient:a case report. Indian J Thorac Cardiovasc Surg. 2023 Sep;39(5):535-538. doi: 10.1007/s12055-023-01524-5. Epub 2023 Jun 14. PMID: 37609612; PMCID: PMC10441853

• Gupta A, Gogia A.Deo S, Sharma DN, Mathur S, Sagiraju HKR. Neoadjuvant chemotherapy with or withoutanthracyclines in combination with single HER2-targeted therapy in HER2-positive breast cancer. Cancer Treat Res Commun. 2023;36:100741. doi: 10.1016/j.ctarc.2023.100741. Epub 2023 Jul 9. PMID: 37453371.

• Pandey P, Sharma A, Gogia A.Bone health in breast cancer. Curr Probl Cancer. 2023 Jun;47(3):100959. doi: 10.1016/j.currproblcancer.2023.100959. Epub 2023 May 5. PMID: 37236055.

• Sharma V, Kumar A, Baa A, Kirar S, Sharma A, Bakhshi S, Gogia A.Malik PS, Rastogi S, Batra A, Pushpam D, Kataria B, Sagiraju H, Sharma A, Singh V. Dexamethasone-free antiemetic strategy for highly emetogenic chemotherapy: safety and efficacy-pilot study.BMJ Support Palliat Care. 2023 Mar 16:spcare-2022-003864. doi: 10.1136/spcare-2022-003864. Epub ahead of print. PMID: 36927873.

• Sg N, Gogia A.Sacituzumab Govitecan in Hormone Receptor-Positive Metastatic Breast Cancer. J Clin Oncol.2023 Mar 10;41(8):1631. doi: 10.1200/JCO.22.02113. Epub 2023 Jan 6. PMID: 36608301.

• Mishra A, Oberoi AS, Deo S, Sharma J, Gogia A.Sharma DN, Mathur S, Dhamija E. Bilateral Breast Cancer: Clinical Profile and Management. Indian J Surg Oncol. 2023 Sep;14(3):651-658. doi: 10.1007/s13193-023-01731-x. Epub 2023 Mar 7. PMID: 37900630; PMCID: PMC10611650.

• Jain S, Goswami A, Lone MR, Ramteke P, Gogia A.Aggarwal M, Viswanathan GK, Kakkar D, Mandal T, Sharma A, Sahoo R, Baldia A, Sharma MC, Bakhshi S, Pramanik R, Dhawan R, Kumar L, Mallick S.Follicular Helper T-Cell-derived Nodal Lymphomas: Study of Histomorphologic, Immunophenotypic, Clinical, and RHOA G17V Mutational Profile. Appl Immunohistochem Mol Morphol. 2023 Mar 1;31(3):172-180. doi: 10.1097/PAI.0000000000001105. Epub 2023 Feb 20. PMID: 36806188.

• Taneja N, Dev T, Patel U, Arava S, Gogia A.Gupta V. Rapidly progressive hyperpigmented keratotic plaques with epidermotropism. Indian J Dermatol VenereolLeprol. 2023 Jan-Mar;8 9(2):283-286. doi: 10.25259/IJDVL_1200_20. PMID: 34379962.

• Mansouri L, Thorvaldsdottir B, Sutton LA, Karakatsoulis G, Meggendorfer M, Parker H, Nadeu F, Brieghel C, Laidou S, Moia R, Rossi D, Catherwood M, Kotaskova J, Delgado J, Rodríguez-Vicente AE, Benito R, Rigolin GM, Bonfiglio S, Scarfo L, Mattsson M, Davis Z, Gogia A.et al Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY.Leukemia. 2023 Feb;37(2):504.

• Mansouri L, Thorvaldsdottir B, Sutton LA, Karakatsoulis G, Meggendorfer M, Parker H, Nadeu F, Brieghel C, Laidou S, Moia R, Rossi D,Catherwood M, Kotaskova J, Delgado J, Rodríguez-Vicente AE, Benito R, Rigolin GM, Bonfiglio S, Scarfo L, Mattsson M, Davis Z, Gogia A.et al Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status:a study by ERIC in HARMONY. Leukemia. 2023 Feb;37(2):504. doi: 10.1038/s41375-023-01813-3. Erratum for: Leukemia. 2023 Feb;37(2):339-347. PMID: 36635392; PMCID: PMC9898025.

• Pandey P, Kumar A, Pushpam D, Khurana S, Malik PS, Gogia A.Arunmozhimaran E, Singh MB, Chandran DS, Batra A. Randomized double-blind, placebo-controlled study of oral gabapentin for prevention of neuropathy in patients receiving paclitaxel. Trials. 2023 Feb 3;24(1):79. doi: 10.1186/s13063-023-07126-1. PMID: 36732774; PMCID: PMC9896696

• Mansouri L, Thorvaldsdottir B, Sutton LA, Karakatsoulis G, Meggendorfer M, Parker H, Nadeu F, Brieghel C, Laidou S, Moia R, Rossi D, Catherwood M, Kotaskova J, Delgado J, Rodríguez-Vicente AE, Benito R, Rigolin GM, Bonfiglio S, Scarfo L, Mattsson M, Davis Z, Gogia A.et al. Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY. Leukemia. 2023 Feb;37(2):339-347. doi: 10.1038/s41375-022-01802-y. Epub 2022 Dec 24.Erratum in: Leukemia. 2023 Jan 12;: PMID: 36566271; PMCID: PMC9898037.

• Dhar A, Srivastava A, Pandey RM, Shrestha P, Villet S, Gogia A.Safety and Efficacy of a Mobiderm Compression Bandage During Intensive Phase of Decongestive Therapy in Patients with Breast Cancer-Related Lymphedema: A Randomized Controlled Trial.Lymphat Res Biol. 2023 Feb;21(1):52-59.

• Rana R, Ranjan V, Kumar N, Chugh P, Khillan K, Gogia A.Rana DS, Ganguly NK.
  Association of underlying comorbidities and progression of COVID-19 infection amongst 2586 patients hospitalised in the National Capital Region of India: a retrospective cohort study.Mol Cell Biochem. 2023 Jan;478(1):149-160.

• Ganguly S, Gogia A.Overall survival with osimertinib in resected EGFR-mutated non-small-cell lung cancerCancer Research, Statistics, and Treatment 6 (4) (2023), 640-641

• Pandey P, Gogia A.Fifteen-year outcomes in prostate cancerCancer Research, Statistics, and Treatment 6 (4) (2023), 635-636

• Mane P, Ramteke P, Singh A, Gogia A.Mallick S,Primary extranodal NK/T cell lymphoma of stomach: A case report and review of literature Indian Journal of Pathology and Microbiology, (2023)10.4103

• Pandey P, Gogia A.Time to question extended adjuvant endocrine therapy for allCancer Research, Statistics, and Treatment 6 (4),(2023) 636-637

• Ganguly S, Gogia A.Perioperative nivolumab and chemotherapy in resectable Stage III non-small-cell lung cancerCancer Research, Statistics, and Treatment 6 (2023)(4), 643

• Ganguly S, Gogia A.Omitting radiation in early-stage breast cancerCancer Research, Statistics, and Treatment 6 (2023)(4), 642-643

• Pandey P, Gogia. AVeneto clax in chronic lymphocytic leukemiaCancer Research, Statistics, and Treatment 6 (2023) (4), 638

• Ganguly S, Gogia A. Capivasertib in advanced hormone receptor-positive breast cancerCancer Research, Statistics, and Treatment 6 (2023)(4), 633

• Pandey P, Gogia A. Sacituzumab govitecan: A narrative drug reviewCancer Research, Statistics, and Treatment 6 (4)(2023), 562-572

• Ganguly S, Gogia A.Preoperative treatment in locally advanced rectal cancerCancer Research, Statistics, and Treatment 6 (4)(2023), 641-642

• Ganguly S, Gogia A. Pembrolizumab in advanced endometrial cancerCancer Research, Statistics, and Treatment 6 (4)(2023), 631-632

• R Pramanik, S Vats, S Mitra, SVS Deo, L Kumar, Gogia. A, Khurana S,et al Assessment of Knowledge and Attitude of Breast and Ovarian Cancer Patients Regarding Hereditary Breast-Ovarian Cancer Syndrome at a Tertiary Cancer Institute: A Cross-Sectional studyIndian Journal of Medical and Paediatric Oncology 2023

• Pandey P, Gogia A.Sequencing therapies for metastatic hormone receptor-positive breast cancerCancer Research, Statistics, and Treatment (2023)6 (4), 639

• Pandey P, Gogia A. Anthracycline-and taxane-containing chemotherapy for early-stage breast cancer, Cancer Research, Statistics, and Treatment 6 (4) (2023), 633-634

• Pandey P, Gogia A. Protocol amendment in clinical trialsCancer Research, Statistics, and Treatment 6 (4)(2023), 645

• Ganguly S, Gogia A. Perioperative pembrolizumab in early-stage non-small-cell lung cancerCancer Research, Statistics, and Treatment 6 (4)(2023), 644

• Pandey P, Gogia A. Empowering breast cancer survivors: Nurturing self-compassion for a positive body image Cancer Research, Statistics, and Treatment 6 (4) (2023), 581-583

• Pandey P, Gogia. A Cabozantinib plus nivolumab and ipilimumab in renal cell carcinomaCancer Research, Statistics, and Treatment 6 (4)(2023), 635

• Ganguly S, Gogia A. Dostarlimab in recurrent endometrial cancerCancer Research, Statistics, and Treatment 6 (4)(2023), 632

• Upadhya S, Gogia A. Interrupting endocrine therapy in hormone-positive early breast cancerCancer Research, Statistics, and Treatment 6 (4), (2023) 639-640

• Pandey P, Gogia A. Rucaparib in metastatic prostate cancerCancer Research, Statistics, and Treatment 6 (2) (2023), 360-361.

• Chib S, Gogia.A Apatinib plus pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancer Cancer Research, Statistics, and Treatment 5 (4), 793-794 (2023)

• Pandey P, Gogia A. Neoadjuvant pembrolizumab in advanced melanoma Cancer Research, Statistics, and Treatment 6 (2)(2023), 360

• Mallick S, Pandey P, Gogia A. Breast-conserving surgery without irradiation in early breast cancer ,Cancer Research, Statistics, and Treatment 6 (2)(2023), 361-362

• Oberoi AS, Deo SVS, Bhoriwal S, Sharma DN, Gogia.A, Mathur S.Treatment patterns in breast cancer: Real world data audit from tertiary care cancer center in LMICEuropean Journal of Surgical Oncology 49 (5) 2023, e230-e231

• Jain S, Ramteke P, Gogia A.Mandal T, Aggarwal M, Dass J, Sharma MC, Mahapatra M, Parmanik R, Bakhshi S, Sharma A, Mallick S. Splenic Lymphomas: A Tertiary Care Center Experience and Review of Literature. Indian J Hematol Blood Transfus. 2023 Jul;3 9(3):402-412. doi: 10.1007/s12288-022-01621-2. Epub 2022 Dec 28. PMID: 37304493; PMCID: PMC10247621.

• Ganguly S, Gogia A.Pembrolizumab as adjuvant therapy in non-small-cell lung cancer. Lancet Oncol. 2022 Dec;23(12):e528. doi: 10.1016/S1470-2045(22)00652-0. PMID: 36455577.

• Tarigopula V, Nayak P, Mandal S, Das MK, Tripathy S.Gogia A.Clarification needed for pembrolizumab as adjuvant therapy in clear cell renal cell carcinoma. Lancet Oncol. 2022 Nov;23(11):e487. doi: 10.1016/S1470-2045(22)00601-5. PMID: 36328016.

• Ganguly S, Gogia A.Clarification needed for pembrolizumab as adjuvant therapy in clear cell renal cell carcinoma.Lancet Oncol. 2022 Nov;23(11):e488. doi: 10.1016/S1470-2045(22)00602-7.PMID: 36328017 No abstract available.

• Jain S, Mandal T, Ramteke P, Sharma MC, Gogia A.Aggarwal M, Bakhshi S, Mallick S.Application of the Proposed Immunohistochemistry Algorithm for the Prognostication of GATA3 and TBX21 Subtypes of Peripheral T-Cell Lymphoma, Not Otherwise Specified.Clin Lymphoma Myeloma Leuk. 2022 Oct;22 Suppl 2:S398.

• Chib S, Gogia A.Doxorubicin plus trabectedin for metastatic or unresectable leiomyosarcoma.Lancet Oncol. 2022 Oct;23(10):e443.

• Ganguly S, Gogia A.PD-1 Blockade in Mismatch Repair-Deficient Rectal Cancer.N Engl J Med. 2022 Sep 1;387(9):855.

• Kumar R, Ningombam SS, Kumar R, Goel H, Gogia A.Khurana S, Deo SVS, Mathur S, Tanwar P.Comprehensive mutations analyses of FTO (fat mass and obesity-associated gene) and their effects on FTO's substrate binding implicated in obesity.FrontNutr. 2022 Jul 18;9:852944.

• Gupta G, Garg V, Mallick S, Gogia A.Current trends in diagnosis and management of follicular lymphoma. Am J Blood Res. 2022 Aug 15;12(4):105-124. PMID: 3647608; PMCID: PMC9490109.

• Mittal A, Deo SVS, Gogia A.Batra A, Kumar A, Bhoriwal S, Deb KS, Dhamija E, Ramprasad VL, Olopade O, Pramanik R. Spectrum and management of breast cancer patients with variant of uncertain significance mutations at a tertiary care centre in North India. Ecancermedicalscience. 2022 Aug 1;16:1434. doi: 10.3332/ecancer.2022.1434. PMID: 36200007; PMCID: PMC9470172.

• Pulappadi VP, Dhamija E, Baby A, Mathur S, Pandey P, Gogia A.Deo SVS. Imaging Features of Breast Cancer Subtypes on Mammography and Ultrasonography: an Analysis of 479 Patients. Indian J Surg Oncol. 2022 Dec;13 (4):931-938. doi: 10.1007/s13193-022-01606-7. Epub 2022 Aug 1. PMID: 36687228; PMCID: PMC9845486.

• Ganguly S, Gogia A.Capecitabine Maintenance in Metastatic Nasopharyngeal Carcinoma. JAMA Oncol. 2022 Aug 1;8(8):1223-1224. doi: 10.1001/jamaoncol.2022.2062. PMID: 35771541.

• Pulappadi VP, Dhamija E, Baby A, Mathur S, Pandey P, Gogia A.Deo SV. ImagingFeatures of Breast Cancer Subtypes on Mammography and Ultrasonography: anAnalysisof 479 Patients. Indian Journal of Surgical Oncology. 2022 Aug 1:1-8.

• Ganguly S, Gogia A.Rucaparib for recurrent ovarian cancer with BRCA1 and BRCA2 mutations. Lancet Oncol. 2022 Jul;23(7):e314. doi: 10.1016/S1470-2045(22)00325-4. PMID: 35772456.

• Pautier P, Italiano A, Piperno-Neumann S, Chevreau C, Penel N, Firmin N, Boudou-Rouquette P, Bertucci F, Balleyguier C, Lebrun-Ly V, Ray-Coquard I, Kalbacher E, Bardet A, Bompas E, Collard O, Isambert N, Guillemet C, Rios M, Archambaud B, Duffaud F; French Sarcoma Group. Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy formetastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial. Lancet Oncol. 2022 Aug;23(8):1044-1054. doi: 10.1016/S1470-2045(22)00380-1. Epub 2022 Jul 11. PMID: 35835135.

• Mukherjee Das A,Gogia A.Janardhanan R, Babu-Rajendran R, Das BC. EnvironmentalContamination and Chronic Exposure to Endocrine-Disrupting Phthalates: AnOverlooked and Emerging Determinant for Hormone-Sensitive Cancers. Journal of theIndian Institute of Science. 2022 Jul 20:1-2.

• Prasad CP, Batra A. Essential role of aerobic glycolysis in epithelial-to-mesenchymal Gogia A.transition during carcinogenesis. Clin Transl Oncol. 2022 Oct;24(10):1844-1855. doi: 10.1007/s12094-022-02851-6. Epub 2022 Jun 25. PMID: 35751743.

• Jain S, Mallick S, Ramteke P, Gogia A.Neoplasms of follicular helper T-cells: an insight into the pathobiology. Am J Blood Res. 2022 Jun 20;12 (3):64-81. PMID: 35873103; PMCID: PMC9301021.

• Mukherjee Das A, Gogia A.Garg M, Elaiyaraja A, Arambam P, Mathur S, Babu-Rajendran R, Deo SVS, Kumar L, Das BC, Janardhanan R. Urinary concentration of endocrine-disrupting phthalates and breast cancer risk in Indian women: A case-control study with a focus on mutations in phthalate-responsive genes. Cancer Epidemiol. 2022 Aug;7 9:102188. doi: 10.1016/j.canep.2022.102188. Epub 2022 Jun 7. PMID: 35688051.

• Kumar A, Baghmar S, Mehta P, Tiwari P, Kumar L, Bakhshi S, Agarwal A, Gupta I, Trikha A, Bhatnagar S, Gogia A.Characteristics& outcomes of cancer patients with COVID-19: A multicentre retrospective study from India.Indian J Med Res. 2022May-Jun;155(5&6):546-553.doi10.4103/ijmr.ijmr_1703_21.PMID: 36348601 

• Das N, Dahiya M, Gupta R, Rai S, Singh S, Prajapati VK, Kumar L, Sharma A, Sahoo RK, Gogia A.Flow cytometric immunophenotyping of plasma cells across the spectrum of plasma cell proliferative disorders: A fresh insight with pattern-basedrecognition. Cytometry B Clin Cytom. 2022 Jul;102(4):292-302. doi: 10.1002/cyto.b.22062. Epub 2022 Feb 25. PMID: 35212134.

• Pulappadi VP, Paul S, Hari S, Dhamija E, Manchanda S, Kataria K, Mathur S, Mani K, Gogia A.Deo S. Role of shear wave elastography as an adjunct to axillary ultrasonography in predicting nodal metastasis in breast cancer patients with suspicious nodes. Br J Radiol. 2022 Jun 1;95(1134):20220055. doi: 10.1259/bjr.20220055. Epub 2022 Mar 28. PMID: 35290097.

• Kumar A, Baghmar S, Mehta P, Tiwari P, Kumar L, Bakhshi S, Agarwal A, Gupta I, Trikha A, Bhatnagar S, Gogia A.Malik PS, Sahoo RK, Rastogi S, Pramanik R, Batra A, Pushpam D, Sharma CK, Sharma V, Kataria B, Goyal K, Samaga S, Bothra SJ, Sharma A. Characteristics & outcomes of cancer patients with COVID-19: A multicentre retrospective study from India. Indian J Med Res. 2022 May-Jun;15 5(5&6):546-553. doi: 10.4103/ijmr.ijmr_1703_21. PMID: 36348601; PMCID: PMC9807197.

• Santhosh A, Kumar A, Pramanik R, Gogia A.Prasad CP, Gupta I, Gupta N, Cheung WY, Pandey RM, Sharma A, Batra A. Randomized double-blind, placebo-controlled study of topical diclofenac in the prevention of hand-foot syndrome in patients receiving capecitabine (the D-TORCH study). Trials. 2022 May 19;23(1):420. doi: 10.1186/s13063-022-06353-2. PMID: 35590388; PMCID: PMC9117836.

• Gogia A.Gupta R, Sharma A, Kumar L, Rani L, Mallick S. Safety and Efficacy of Bendamustine and Rituximab (BR) Regimen in Indian Chronic Lymphocytic Leukaemia Patients. Indian J Hematol Blood Transfus. 2023 Jan;3 9(1):33-39. doi: 10.1007/s12288-022-01544-y. Epub 2022 May 27. PMID: 36699426; PMCID: PMC9868021.

• Santhosh A, Kumar A, Pramanik R, Gogia A.Prasad CP, Gupta I, Gupta N, Cheung WY, Pandey RM, Sharma A, Batra A.Randomized double-blind, placebo-controlled study of topical diclofenac in the prevention of hand-foot syndrome in patients receivingcapecitabine (the D-TORCH study). Trials. 2022 May 19;23(1):420. doi: 10.1186/s13063-022-06353-2. PMID: 35590388; PMCID: PMC9117836.

• Das N, Dahiya M, Gupta R, Kumar L, Sharma A, Rai S, Singh S, Prajapati VK, Sahoo RK, Gogia A. Relevance of polyclonal plasma cells and post-therapy immunomodulation in measurable residual disease assessment in multiple myeloma. Cytometry B Clin Cytom. 2022 May;10 2(3):209-219. doi: 10.1002/cyto.b.22068. Epub 2022 Apr 7. PMID: 35389550.Kumar S, Sharma A, Pramanik R, Pathak N, Gogia A.Kumar A, Kayal S, Sharma V, Sahoo RK, Thulkar S, Sharma MC, Gupta R, Mallick S, Thomas M, Raina V. Long-Term Outcomes and Safety Trends of Autologous Stem-Cell Transplantation in Non-Hodgkin Lymphoma: A Report From A Tertiary Care Center in India. JCO Glob Oncol. 2022 May;8:e2100383. doi: 10.1200/GO.21.00383. PMID: 35561291; PMCID: PMC9302266.

• Kumar S, Sharma A, Malik PS, Gogia A.Pathak N, Sahoo RK, Gupta R, Prasad CP, Kumar L. Bendamustine in combination with pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: A phase II trial. Br J Haematol. 2022 Jul;198(2):288-297. doi: 10.1111/bjh.18200. Epub 2022 May 2. PMID: 35499209.

• Ganguly S, Gogia A.Pembrolizumab in Early Triple-Negative Breast Cancer. N Engl J Med. 2022 May 5;386(18):1771. doi: 10.1056/NEJMc2203316. PMID: 35507497.

• Gogia A.Deo S SV, Sharma DN, Mathur S. Oligometastatic breast cancer: An institutional analysis. Indian J Cancer. 2022 Apr-Jun;5 9(2):257-262. doi: 10.4103/ijc.IJC_169_20. PMID: 35946184.

• Lone M, Shadang M, Akhter Q, Kumar M, Mallick S, Gogia A.Nilima N, Chauhan SS, Mir RA. The Expression of the RUVBL1 Component of the R2TP Complex Correlates with Poor Prognosis in DLBCL. Pathobiology. 2022;89(3):146-156. doi: 10.1159/000520723. Epub 2022 Jan 25. PMID: 35078195.

• S Chib, Ganguly S, Gogia A.Neoadjuvant cemiplimab for stages II to IV cutaneous squamous cell carcinoma Cancer Research, Statistics, and Treatment 5 (4), (2022)799.

• Gogia A. Kumar S, Raina V, Sharma A, Gupta A, A Biswas, Mallick S :- ABCL-398 Primary Breast Diffuse Large B-Cell Lymphoma: An Indian Experience Clinical Lymphoma Myeloma and Leukemia (2022),S375-S376

• Chib S, Ganguly S, Gogia.A :- Neoadjuvantcemiplimabcemiplimab for stages II to IV cutaneous squamous cell carcinomaCancer Research, Statistics, and Treatment 5 (4), 799 (2022).

• Santhosh A, Gogia.A:- Is there an optimal regimen for double hit lymphomas?Cancer Research, Statistics, and Treatment 5 (4), 802-803 (2022)

• Ganguly S, S Bhargava, Gogia. A Brentuximab vedotin in pediatric Hodgkin lymphomaCancer Research, Statistics, and Treatment 5 (4), 800-801 (2022).

• Gogia.A. Kumar S, Raina V, Gupta R:- Poster: AML-194 Second Hematological Malignancies in Survivors of Breast Cancer: An Indian Institutional AnalysisClinical Lymphoma, Myeloma and Leukemia (2022), S130

• Gogia.A S Nair, Kumar S, Sharma A, A Biswas, S Mallik, Gupta R :-Poster: ABCL-200 Primary and Secondary Extranodal Diffuse Large B-Cell Lymphoma: A Single-Center Survey from IndiaClinical Lymphoma, Myeloma and Leukemia (2022), S167

• Gogia.A, Gupta R, Kumar l, Sharma A, L Rani, Mallick SPoster: IBCL-429 Prevalence of B-Cell Chronic Lymphoproliferative Disorders at a Large Tertiary Care Center in IndiaClinical Lymphoma, Myeloma and Leukemia (2022), S174

• Gogia.A Kumar S, Sharma A, Gupta R, Mallick S :- Poster: ABCL-400 Adult Burkitt Lymphoma: An Institutional Experience With Uniform DA-EPOCH-R ProtocolClinical Lymphoma, Myeloma and Leukemia (2022), S169

• Gogia.A, Kumar S, Raina V, Sharma A, Gupta R, Biswas A, Mallick S :-Poster: ABCL-398 Primary Breast Diffuse Large B-Cell Lymphoma: An Indian ExperienceClinical Lymphoma, Myeloma and Leukemia (2022), S169

• A Chaudhary, Gogia.A Gefitinib plus chemotherapy for EGFR-mutant non-small-cell lung cancerCancer Research, Statistics, and Treatment 5 (4), 796-797 (2022)

• Ganguly S, Gogia.A Triplet therapy, transplantation, and maintenance until progression in multiple myeloma Cancer Research, Statistics, and Treatment 5 (4), 801-802 (2022)

• Ganguly S, S Bhargva, Gogia.A:- Pembrolizumab as adjuvant therapy in melanoma Cancer Research, Statistics, and Treatment 5 (4), 799-800 (2022)

• Santhosh A, A.Gogia :- Is the Hans algorithm outdated?Cancer Research, Statistics, and Treatment 5 (4), 792-793 (2022)

• Das AM , Shrivastav KD, Taneja N , Awasthi AA , Rashid S , Gogia.A...Knowledge and awareness of breast cancer and breast self-examination among college-going female students in Delhi-NCR: a cross sectional studyHealth Education 122 (6), 663-677 (2022).

• Santhosh AP, A.Gogia. :- Is fulvestrant the correct choice for early switch with rising ESR1 mutation? Cancer Research, Statistics, and Treatment 5 (4), 798 (2022)

• Ganguly S, A.Gogia. :- Overall survival with brentuximab vedotin in advanced Hodgkin lymphoma Cancer Research, Statistics, and Treatment 5 (4), 794-795

• Pandey P, Gogia.A:- Ibrutinib plus bendamustine and rituximab in untreated mantle cell lymphomaCancer Research, Statistics, and Treatment 2022: 5 (3), 622 (2022)

• Ganguly.S, Gogia.A :- Trastuzumabderuxtecan in HER2-low breast cancer Cancer Research, Statistics, and Treatment 20225 (3), 621-622 (2022)

• Ganguly. S, Gogia.A :-Neoadjuvant nivolumab with chemotherapy in resectable lung cancer Cancer Research, Statistics, and Treatment 2022 5 (3), 620-621 (2022)

• Arora S, Gogia.A Tumour Lysis Syndrome Onco-critical Care: An Evidence-based Approach, 351-360 (2022)

• A Mukherjee Das, Gogia.A , Janardhanan R, R Babu-Rajendran, BC Das :-Environmental contamination and chronic exposure to endocrine-disrupting phthalates: an overlooked and emerging determinant for hormone-sensitive cancersJournal of the Indian Institute of Science 2022102 (2), 731-742 (2022)

• Gogia A. Kumar S, Raina V, Gupta A :AML-194 Second Hematological Malignancies in Survivors of Breast Cancer: An Indian Institutional Analysis Clinical Lymphoma Myeloma and Leukemia (2022), S223

• Gandhi AK, Gogia A. Authors' reply to Agarwal et al. and Iyer Cancer Research, Statistics, and Treatment 5 (1) (2022), 152-153

• Sharma R, Gogia A. Authors' reply to Muddu and Boindala Cancer Research, Statistics, and Treatment 5 (1) (2022), 183-184

• Tansir G, Gogia A. Gupta R. Hydroxyurea-induced hyperpigmentation. Cancer Res StatTreat2022;5:385-6.

• Pandey P, Gogia A. Axicabtageneciloleucel as second-line therapy for large B-celllymphoma. Cancer Res Stat Treat 2022;5:395.

• Gupta A, Gogia A. Lenvatinib plus pembrolizumab for advanced endometrial cancer.Cancer Res Stat Treat 2022;5:351.

• Sasi A, Gogia A. Preventing central nervous system relapses of diffuse large B-celllymphoma: A brief summary of current evidence. Cancer Res Stat Treat 2022;5:396-7.

• Kirar S, Gogia A. An unusual presentation of breast cancer: Upfront colonic and stomachmetastases. Cancer Res Stat Treat 2022;5:398-9.

• Ganguly S, Gogia A.Trastuzumab deruxtecan versus trastuzumab emtansine for breastcancer. Cancer Res Stat Treat 2022;5:393.

• Ganguly S, Gogia A. Overall survival with ribociclib and letrozole in advancedpostmenopausal hormone receptor–positive breast cancer. Cancer Res Stat Treat. 2022;5:393-4.

• Pandey P, Gogia A.Tisagenlecleucel in aggressive B-cell lymphoma. Cancer Res StatTreat2022;5:394-5.

• Gupta A, Gogia A. Ribociclib-induced flagellate rash. Cancer Res Stat Treat 2022;5:397-8.

• Ganguly S, Gogia A. reply to Kakoti and Laskar. Cancer Res Stat Treat2022;5:380-1.

• Goyal K, Gogia A. Ibrutinib-rituximab in Waldenstrom's macroglobulinemia. Cancer ResStat Treat 2022;5:351-2.

• Pandey P, Gogia A. Polatuzumabvedotin in previously untreated diffuse large B-celllymphoma. Cancer Res Stat Treat 2022;5:350.

• Kirar S, Gogia A. Gupta R. ATRA-induced myositis. Cancer Res Stat Treat 2022;5:386-388.

• Sharma A, Gogia A. Gupta R. Pleural effusion as an unusual presentation of chroniclymphocytic leukemia. Cancer Res Stat Treat 2022;5:388-9.

• Sharma R, Gogia A. Baa AK. Microbiota as a predictor of mortality in allogeneic hematopoietic cell transplantation. Cancer Res Stat Treat 2022;5:191-2.

• Nair SC, Gogia A. Arora S, Kumar L, Sharma A, Biswas A, Gupta R, Mallick S.Clinicopathologic features and outcomes of diffuse large B-cell lymphoma withextranodal involvement: A retrospective analysis. Cancer Res Stat Treat 2022;5:67-74.

• Gandhi AK, Gogia A. reply to Agarwal et al. and Iyer. Cancer Res Stat Treat2022;5:152-3.

• Ganguly S, Gogia A. Secondary cytoreductive surgery in recurrent ovarian carcinoma.Cancer Res Stat Treat 2022;5:192-3.

• Ganguly S, Gogia A.Relatlimab and nivolumab in untreated advanced melanoma.Cancer Res Stat Treat 2022;5:196-7.

• Ganguly S, Gogia A.Trastuzumab deruxtecan in HER2-mutant non-small-cell lungcancer. Cancer Res Stat Treat 2022;5:195-6.

• Sharma R, Gogia A. Reply to Muddu and Boindala. Cancer Res Stat Treat2022;5:183-4.

• Raodha R, Gogia A. Baa A. Adjuvant pembrolizumab in renal cell carcinoma. CancerRes Stat Treat 2022;5:191.

• Baa AK, Gogia A.Vemurafenib plus rituximab in relapsed or refractory hairy cellleukemia. Cancer Res Stat Treat 2022;5:188.

• Gogia A.Nair S, Arora S, Kumar L, Sharma A, Gupta R, Biswas A, Mallick S. Impact of Cell-of-Origin on Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Uniform R-CHOP Protocol: A Single-Center Retrospective Analysis From North India. Front Oncol. 2021 Dec 2;11:770747. doi: 10.3389/fonc.2021.770747. PMID: 34926277; PMCID: PMC8675100.

• Deo SV, Chhebbi M, Mishra A, Sharma J, Gogia A. Pramanik R. A Review of SurgicalPerspectives of Breast Cancer Genetics and Risk-Reducing Surgery. Indian Journal ofSurgery. 2021 Nov 25:1-6.

• Mittal A, Deo SVS, Gogia A. Batra A, Kumar A, Bhoriwal S, Deb KS, Dhamija E, Thulkar S, Ramprasad VL, Olopade O, Pramanik R. Profile of Pathogenic Mutations and Evaluation of Germline Genetic Testing Criteria in Consecutive Breast Cancer Patients Treated at a North Indian Tertiary Care Center. Ann Surg Oncol. 2022 Feb;29(2):1423-1432. doi: 10.1245/s10434-021-10870-w. Epub 2021 Oct 2. PMID: 34601666; PMCID: PMC8487333.

• Ganguly S, Gogia A.Sacituzumab Govitecan in Metastatic Breast Cancer. N Engl J Med.2021 Jul 15;385(3):e12.

• Ganguly S, Gogia A.Adjuvant olaparib in germline BRCA-mutated breastcancer–Standard of care for all?. Cancer Research, Statistics, and Treatment. 2021 Jul1;4(3):600.

• Ganguly S, Gogia A.Extending adjuvant endocrine therapy in hormone receptor-positivebreast cancer: An Indian perspective. Cancer Research, Statistics, and Treatment. 2021Jul 1;4(3):602.

• Arundhathi JRD, Mathur SR, Gogia A.Deo SVS, Mohapatra P, Prasad CP. Metabolicchanges in triple negative breast cancer-focus on aerobic glycolysis. Mol Biol Rep. 2021 May;48(5):4733-4745

• Sharma A, Kumar S, A. Gogia, Gupta R, Thulkar S, Pramanik R, Sharma MC, Raina V. Autologous Stem Cell Transplant in Non Hodgkin Lymphoma at Aiims: Trends in Tolerability And Long Term Outcomes. In Bone Marrow Transplantation 2021 Jun 1 (Vol. 56, No. Suppl 1, Pp. 279-280). Campus, 4 Crinan St, London, N1 9xw, England: Springernature.

• Jain S, Lone MR, Goswami A, Mandal T, Panda AK, Ramteke P, Srivastav T, SharmaMC, Gogia A.Sharma A, Bakhshi S, Mahapatra M, Kumar L, Mallick S. Lymphomasubtypes in India: a tertiary care center review. Clin Exp Med. 2021 May;21(2):315-321

• Gogia A.Mittal A, Sharma A, Sagiraju HKR. Short-duration adjuvant trastuzumabtherapy in human epidermal growth factor receptor 2-positive breast cancers: Has its timecome? Natl Med J India. 2021 Mar-Apr;34(2):90-91. doi: 10.4103/0970-258X.326770.

• Gogia A.Kumar S, Chellapurum SK, Biswas A, Mallick S. Primary Mediastinal B CellLymphoma: A Limited Institutional Experience with Uniform DAEPOCH-R Protocol.Indian J Hematol Blood Transfus. 2021 Jan;37(1):176-178. doi: 10.1007/s12288-020

• Mishra S, Gogia A.Satapathy S, GOGIA A.Sharma A, Bhatnagar S. Caregiver Burden andQuality of Life among Family Caregivers of Cancer Patients on Chemotherapy: AProspective Observational Study. Indian J Palliat Care. 2021 Jan-Mar;27(1):109-112.

• Arora S, Gogia A.Recent updates in systemic therapy of breast cancer: A brief narrativereview. Cancer Research, Statistics, and Treatment. 2021 Jan 1;4(1):99.

• Arora S, Gogia A.Deo S, Sharma D, Mathur SR. Neoadjuvant pertuzumabplustrastuzumab in combination with anthracycline- free chemotherapy regimen in patientswith HER2 positive breast cancer-Real-world data from a single center in India. CancerTreat Res Commun. 2021; 29:100483. doi: 10.1016/j.ctarc.2021.100483.

• Pulappadi VP, Paul S, Hari S, Dhamija E, Manchanda S, Kataria K, Mathur S, Mani K, Gogia A.Deo S. Axillary ultrasonography combined withpre-operative wire localisation of clipped node in nodal restaging after neoadjuvant chemotherapy in node positive breast cancer patients:a pilot study. Br J Radiol. 2021 Nov 1;94(1127):20210788. doi: 10.1259/bjr.20210788. Epub 2021 Sep 7. PMID: 34491822; PMCID: PMC8553197.

• Das N, Gupta R, Gupta SK, Bakhshi S, Seth R, Kumar C, Rai S, Singh S, Prajapati VK, Gogia A.Sahoo RK, Sharma A, Kumar L. Critical evaluation of the utility of pre- and post-therapy immunophenotypes in assessment of measurable residual disease in B-ALL. Ann Hematol. 2021 Oct;100(10):2487-2500. doi: 10.1007/s00277-021-04580-2. Epub 2021 Jul 8. PMID: 34236495.

• Ganguly S, Gogia A.Sacituzumab Govitecan in Metastatic Breast Cancer. N Engl J Med. 2021 Jul 15;385(3):e12. doi: 10.1056/NEJMc2108478. PMID: 34260847.

• Ganguly S, Gogia A.Pembrolizumab monotherapy in advanced triple-negative breast cancer. Lancet Oncol. 2021 Jun;22(6):e224. doi: 10.1016/S1470-2045(21)00249-7. PMID: 34087134.

• Dhamija E, Gulati M, Deo SVS, Gogia A.Hari S. Digital Breast Tomosynthesis: an Overview. Indian J Surg Oncol. 2021 Jun;12(2):315-329. doi: 10.1007/s13193-021-01310-y. Epub 2021 May 15. PMID: 34295076; PMCID: PMC8272763.

• Bhoriwal S, Deo SVS, Kumar R, Thulkar S, Gogia A.Sharma DN, Mathur S.A Prospective Study Comparing the Role of 18 FDG PET-CTwith Contrast-Enhanced Computed Tomography and Tc99m Bone Scan for Staging LocallyAdvanced Breast Cancer. Indian J Surg Oncol. 2021 Jun;12(2):266-271. doi: 10.1007/s13193-021-01299-4. Epub 2021 Mar 2. PMID: 34295069; PMCID: PMC8272774.

• Ganguly S, Gogia A.Adjuvant olaparib in germline BRCA-mutated breast cancer–Standard of care for all? Cancer Research, Statistics, and Treatment 4 (3)(2021), 600-601

• Ganguly S, Gogia A.Extending adjuvant endocrine therapy in hormone receptor-positive breast cancer: An Indian perspective Cancer Research, Statistics, and Treatment 4 (3), 602-603(2021).

• Choudhary P, Gogia A.Deo S V, Sharma D, Mathur SR, Batra A, Raju SagirajuHK. Correlation of pathological complete response with outcomes in locally advanced breastcancer treated with neoadjuvant chemotherapy: An ambispective study. Cancer Res StatTreat2021;4:611-20.

• Sharma RK, Gogia A.Management of triple-negative breast cancer in the era of noveltherapies: A narrative review. Cancer Res Stat Treat 2021;4:668-76.

• Ganguly S, Gogia A.Cabozantinib for radioiodine-refractory progressive differentiatedthyroid cancer. Cancer Res Stat Treat 2021;4:806.

• Sasi A, Gogia A.Nivolumab in relapsed malignant mesothelioma: Is it ‘CONFIRM’ed?.Cancer Res Stat Treat 2021;4:809-10.

• Ganguly S, Gogia A.Pembrolizumab in recurrent or metastatic cervical cancer. CancerRes Stat Treat 2021;4:808-9.

• Kumar S, Gogia A.Gupta R, Mallick S. Chronic Lymphocytic Leukemia withDermatomyositis: A Therapeutic Challenge. Turk J Haematol. 2020 Nov 19;37(4):291

• Vanidassane I, Gogia A.Raina V, Tiwari P. Breast cancer associated with paraneoplastic cerebellar degeneration: A case series.Indian J Cancer. 2020 Oct-Dec;57(4):487-488. doi: 10.4103/ijc.IJC_132_19.PMID: 33078760 No abstract available.

• Kirar S, Gogia A.Gupta R, Mallick S. Ibrutinib-Induced Skin Rash. Turk J Haematol.2021 Feb 25;38(1):81-83. doi: 10.4274/tjh.galenos.2020.2020.0120. Epub 2020 Oct 15.

• Umar SM, Kashyap A, Kahol S, Mathur SR, Gogia A.Deo SVS, Prasad CP. Prognostic and therapeutic relevance of phosphofructokinase platelet-type (PFKP) in breast cancer.Exp Cell Res. 2020 Nov 1;396(1):112282. doi: 10.1016/j.yexcr.2020.112282. Epub 2020 Sep 11.PMID: 32919954

• Mittal A, GOGIA A.Mallick S. Diffuse Large B-Cell Lymphoma presenting as isolated pleural effusion with excellent response to R-PEPC regimen. Indian J Cancer. 2020 Jul-Sep;57(3):351-353

• Gogia A.Kumar S, Kumar L, Sharma A, Mallick S. Safety and Efficacy ofBendamustine-Rituximab in Treatment Naïve Symptomatic Follicular Lymphoma: AnInstitutional Analysis. Indian J Hematol Blood Transfus. 2021 Jan;37(1):169-170. doi:1007/s12288-020-01294-9. Epub 2020 Jun 9. PMID: 33707853; PMCID:

• Das N, Gupta R, Gupta SK, Bakhshi S, Malhotra A, Rai S, Singh S, Prajapati VK, Sahoo RK, Gogia A.Sharma A, Kumar L. A Real-world Perspective of CD123 Expression in Acute Leukemia as Promising Biomarker to Predict Treatment Outcome in B-ALL and AML.ClinLymphoma Myeloma Leuk. 2020 Oct;20(10):e673-e684. doi: 10.1016/j.clml.2020.05.004. Epub 2020 May 11.PMID: 32561191

• SK Chellapuram, Gogia A.Systemic therapy for breast cancer during SARS-CoV-2 pandemic Cancer Research, Statistics, and Treatment. 2020; 3 (5), 35

• S Arora and Gogia A. Cutaneous T-cell lymphoma. The Journal of Medical Research. 2020; 152 (Suppl 1), S48

• A Mittal, Gogia A. Adding ovarian suppression to tamoxifen for pre-menopausal breast cancer. National Medical Journal of India, 2020. 33(5)

• SK Chellapuram, Gogia A. Authors' reply to D'Souza et al. Cancer Research, Statistics, and Treatment. 2020; 3 (2), 334

• A Garg, Gogia A. Mallick S, Gupta A. B-Acute lymphoblastic leukemia in a follow-up case of breast cancer. Indian Journal of Medical and Paediatric Oncology. 2020; 41 (01), 99-101

• Gogia A. Deo SVS, Sharma D, Phulia RK, Thulkar S, Malik PS, Mathur S.Discordance in Biomarker Expression in Breast Cancer After Metastasis: Single Center Experience in India.J Glob Oncol. 2019 Apr;5:1-8. doi: 10.1200/JGO.18.00184.

• Gogia A. Deo SVS, Sharma D, Thulkar S, Kumar R, Malik PS, Mathur S.Clinicopathologic Characteristics and Treatment Outcomes of Patients With Up-Front Metastatic Breast Cancer: Single-Center Experience in India.J Glob Oncol. 2019 Mar;5:1-9. doi: 10.1200/JGO.18.00265.

• Singh A, Purkait S, Mallick S, Ramteke P, Das CK, Gogia A.Sharma MC, Kumar L.Clinicopathological Profile of Castleman's Disease in Indian Population: Experience from a Tertiary Care Center.Indian J Hematol Blood Transfus. 2020 Apr;36(2):254-259.

• Singh A, Purkait S, Mallick S, Ramteke P, Das CK, Gogia A. Sharma MC, Kumar L. Clinicopathological Profile of Castleman's Disease in Indian Population: Experience From a Tertiary Care Center.Indian J Hematol Blood Transfus. 2020 Apr;36(2):254-259

• Kaur G, Ruhela V, Rani L, Gupta A, Sriram K, Gogia A.Sharma A, Kumar L.RNA-Seq profiling of deregulated miRs in CLL and their impact on clinical outcome.Blood Cancer J. 2020 Jan 13;10(1):6. doi: 10.1038/s41408-019-0272-y.PMID: 31932582  

• Sood, A., Ranjan, P., Gogia A.et al. Gentle Chemotherapy in Breast Cancer. Indian J Surg (2020).

• Das N, Thakral D, Singh G, Malhotra A, Phulware RH, Gogia A.Gupta R.FLI1 and MIC2 expression in precursor B-lymphoblastic leukemia with Burkitt-like morphology and extensive extramedullary involvement: A diagnostic challenge in pediatric small round cell tumor.Indian J PatholMicrobiol. 2019 Oct-Dec;62(4):614-617. doi: 10.4103/IJPM.IJPM_520_18.

• Vanidassane I, Gogia A.Mallick S.Adult ALK-positive diffuse large B-cell lymphoma: A limited institutional experience.Indian J Cancer. 2019 Oct-Dec;56(4):373-374. doi: 10.4103/ijc.IJC_705_18.

• Pramanik R, Sharma A, Sharma A, Gogia A.Sahoo RK, Malik PS, Padma MV, Cyriac SL, Kumar L.POEMS Syndrome: Indian Experience from a Tertiary-Care Institute.Clin Lymphoma Myeloma Leuk. 2019 Sep;19(9):e536-e544. doi: 10.1016/j.clml.2019.05.018

• Vanidassane I, Gogia A.Raina V, Gupta R.Treatment Related Acute Myeloid Leukemia in Breast Cancer Survivors: A Single Institutional Experience.Indian J Hematol Blood Transfus. 2019 Jul;35(3):561-562. doi: 10.1007/s12288-019-01078-w. Epub 2019 Feb 4.

• Kumar R, Kumar S, Gogia A.Kakkar A, Mathur SR.Laryngeal metastases from breast cancer: A rare clinical entity.CurrProbl Cancer. 2019 Apr;43(2):130-134. doi: 10.1016/j.

• Mittal A, Gogia A.Mallick S, Gupta R.Leukemia Cutis: A Rare Initial Presentation of Chronic Lymphocytic Leukemia.Indian J Hematol Blood Transfus. 2019 Apr;35(2):367-368. doi: 10.1007/s12288-018-1057-3.

• Garg V, Gogia A.Gupta G.Upfront Lenalidomide in Follicular Lymphoma: Time has Come or Not?Indian J Hematol Blood Transfus. 2019 Apr;35(2):362-363. doi: 10.1007/s12288-018-1046-6.

• Patekar M, Adhikari N, Biswas A, Raina V, Kumar L, Mohanti BK, Gogia A.Sharma A, Batra A, Bakhshi S, Garg A, Thulkar S, Sharma MC, Vishnubhatla S, Baghmar S, Sahoo RK.Primary CNS Lymphoma in India: A 17-Year Experience from the AllIndia Institute of Medical Sciences.J Glob Oncol. 2019 Feb;5:1-9. doi: 10.1200/JGO.18.00124.

• Gogia A.Gupta R, Kumar L, Sharma A, SoniL.Chronic lymphocytic leukemia with deletion 17p: An Indian scenario.South Asian J Cancer. 2019 Jan-Mar;8(1):40. doi: 10.4103/sajc.sajc_287_18.

• A Kakkar, S Purkait, S Agarwal, Mallick S, Gogia A. AK Karak, MC Sharma.Primary thyroid lymphoma: A series from a tertiary care center in Northern India. Journal of cancer research and therapeutics 15 (3), 669 2019

• I Vanidassane, Gogia A. V Sharma, Mallick S. Hodgkin Variant of Richter's Transformation: Is Transplant Always an Answer?.Indian Journal of Medical and Paediatric Oncology. 2019; 40 (02), 307-308

• Sharma M, Gogia A. Deo SSV, Mathur S.Role of re-biopsy in metastatic breast cancer at progression.CurrProbl Cancer. 2019 Oct;43(5):438-442. doi: 10.1016/j.currproblcancer.2018.12.001. Epub 2018 Dec 10.

• Francis Thottian AG, Gandhi AK, Ramateke PP, Gogia A..Acinic cell carcinoma of parotid gland with cavernous sinus metastasis: A case report.J Cancer Res Ther. 2018 Oct-Dec;14(6):1428-1430. doi: 10.4103/0973-1482.192850.

• Gogia A. Raina V, Deo SVS, Shukla NK, Mathur S, Mohanti BK, Sharma DN.Clinico-pathological characteristics and treatment outcome in invasive lobular carcinoma of the breast: An Indian experience.Indian J Cancer. 2018 Oct-Dec;55(4):344-347. doi: 10.4103/ijc.IJC_428_18.

• Gogia A. Deo SV, Shukla NK, Mathur S, Sharma DN, Tiwari A.Clinicopathological profile of breast cancer: An institutional experience.Indian J Cancer. 2018 Jul-Sep;55(3):210-213. doi: 10.4103/ijc.IJC_73_18.

• Vanidassane I, Gogia A.Kumar L.Contemporary hormonal contraceptives and breast cancer risk: What do we learn?. Natl Med J India. 2018 May-Jun;31(3):156-157. doi: 10.4103/0970-258X.255759. No abstract available.

• Rani L, Gogia A.Singh V, Kumar L, Sharma A, Kaur G, Gupta R.Comparative assessment of prognostic models in chronic lymphocytic leukemia: evaluation in Indian cohort.AnnHematol. 2019 Feb;98(2):437-443. doi: 10.1007/s00277-018-3525-0. Epub 2018 Oct 18.

• Nair R, Kakroo A, Bapna A, Gogia A.Vora A, et al. Management of Lymphomas: Consensus Document 2018 by an Indian Expert Group.Indian J Hematol Blood Transfus. 2018 Jul;34(3):398-421. doi: 10.1007/s12288-018-0991-4. Epub 2018 Aug 3.

• Gupta VG, Gogia A. Sharma V, MallickS.LymphomatoidGranulomatosis with Isolated Cutaneous Lesions: Prolonged Remission After DA-EPOCH ProtocolTurk J Haematol. 2018 Aug 3;35(3):213-214

• Natarajan H, Kumar L, Bakhshi S, Sharma A, Velpandian T, Kabra M, Gogia A. Ranjan Biswas N, Gupta YK.Imatinib trough levels: a potential biomarker to predict cytogenetic and molecular response in newly diagnosed patients with chronic myeloid leukemia.Leuk Lymphoma. 2019 Feb;60(2):418-425. doi: 10.1080/10428194.2018.1485907. Epub 2018 Aug 20.

• Adhikari N, Biswas A, Gogia A. Sahoo RK, Garg A, Nehra A, Sharma MC, Bhasker S, Singh M, Sreenivas V, Chawla R, Joshi G, Kumar L, Chander S.A prospective phase II trial of response adapted whole brain radiotherapy after high dose methotrexate based chemotherapy in patients with newly diagnosed primary central nervous system lymphoma-analysis of acute toxicity profile and early clinical outcome.JNeurooncol. 2018 Aug;139(1):153-166.

• Gogia A.Das CK, Kumar L, Sharma A, Tiwari A, Sharma MC, Mallick S. Profile of non-Hodgkin lymphoma: An Indian perspective. South Asian J Cancer 2018 7 (3), 162-163.

• Gogia A.Das CK, Kumar L, Sharma A, Tiwari A, Sharma MC, Mallick S. Diffuse large B-cell lymphoma: An institutional analysis South Asian J Cancer 2018; 7 (3), 200-202.

• Gogia A.Raina V, Deo SVS, Shukla NK, Mathur S, Sharma DN.Neoadjuvant chemotherapy in locally advanced invasive lobular carcinoma: A limited institutional experience.South Asian J Cancer. 2018 Jan-Mar;7(1):64-65.

• M Patekar, Gogia A. A Tiwari, Kumar L, Sharma A, SR Mallick. Adult Burkitt lymphoma: An institutional experience with a uniform chemotherapy protocol. South Asian Journal of Cancer. 2018; 7(03), 195-199

• Gogia A. J Nigade, C Desai, BK Govind, C Deshmukh, B Swarup. Trastuzumab emtansine: Antibody-drug conjugate in treatment of human epidermal growth factor receptor-2-positive metastatic breast cancer. Indian Journal of Medical and Paediatric Oncology. 2018; 39 (01), 79-87

• GuptaVG, Gogia A. KumarL, SharmaA, BakshiS, SharmaMC. Combined modality treatment with “dexamethasone, methotrexate, ifosfamide, l-asparaginase, and etoposide” chemotherapy and involved field radiotherapy. Indian Journal of Medical and Paediatric Oncology. 2018; 39(01), 67-72

• Das ChK, Gogia A. Kumar L, Sharma A, Sharma MCh, Mallick SR.Mantle Cell Lymphoma: A North Indian Tertiary Care Centre ExperienceAsian Pac J Cancer Prev. 2016 Oct 1;17(10):4583-4586.

• Harivenkatesh N, Kumar L, Bakhshi S, Sharma A, Kabra M, Velpandian T, Gogia A. Shastri SS, Gupta YK.Do polymorphisms in MDR1 and CYP3A5 genes influence the risk of cytogenetic relapse in patients with chronic myeloid leukemia on imatinibtherapy?Leuk Lymphoma. 2017 Sep;58(9):1-9.

• Harivenkatesh N, Kumar L, Bakhshi S, Sharma A, Kabra M, Velpandian T, Gogia A. Shastri SS, Biswas NR, Gupta YK.Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in newly diagnosed patients with chronic myeloid leukemia.Pharmacol Res. 2017 Jun;120:138-145.

• Rani L, Mathur N, Gupta R, Gogia A. Kaur G, Dhanjal JK, Sundar D, Kumar L, Sharma A.Genome-wide DNA methylation profiling integrated with gene expression profiling identifies PAX9as a novel prognostic marker in chronic lymphocytic leukemia.Clin Epigenetics. 2017 May 30;9:57.

• Harivenkatesh N, Kumar L, Bakhshi S, Sharma A, Kabra M, Velpandian T, Gogia A. Shastri SS, Biswas NR, Gupta YK. Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in newlydiagnosed patients with chronic myeloid leukemia. Pharmacol Res. 2017 Jun;120:138-145.

• Pramanik R, Gogia A. Malik PS.Metastatic Primary Angiosarcoma of the Breast: Can We Tame It the Metronomic Way.Indian J Med PaediatrOncol. 2017 Apr-Jun;38(2):228-231. doi: 10.4103/ijmpo.ijmpo_156_16.

• Gogia A. Raina V, Kumar L, Sharma A, Sharma MCh, Mallick SR.Follicular lymphoma: an Institutional Analysis. Asian Pac J Cancer Prev. 2017 Mar 1;18(3):681-685.

• Mittal A, Sharma S, Gupta VG, Ragesh R, Nischal N, Gogia A. Soneja M, Das CJ, Sharma SK.Carcinoma of Unknown Primary Presenting as Peripheral Symmetric Gangrene.JAssoc Physicians India. 2017 Feb;65(2):78-81.

• Khanna G, Damle NA, Agarwal S, Roy M, Jain D, Mallick S, Ahmed S, Tripathi M, Gogia A. Mixed Phenotypic Acute Leukemia (mixed myeloid/B-cell) with Myeloid Sarcoma of the Thyroid Gland: A Rare Entity with Rarer Asssociation - Detected on FDG PET/CT.Indian J Nucl Med. 2017 Jan-Mar;32(1):46-49.

• Kumar U, Ramteke P, Das P, Gogia A. TanwarP.Isolated bone marrow metastasis of testicular tumor: A rare cause of thrombocytopenia.Urol Ann. 2017 Jan-Mar;9(1):96-98

• Tiwari A, Gogia A. Deo S, Shukla NK, Mathur S, Sharma DN.Retrospective study of efficacy and safety of neoadjuvantdocetaxel, carboplatin, and trastuzumab in HER2-positive locally advanced and oligometastatic breast cancer: An Indian experience.Indian J Cancer. 2017 Jan-Mar;54(1):343-346. doi: 10.4103/ijc.IJC_152_17.

• Meel R, Dhiman R, Wadhwani M, Kashyap S, Sharma S, Gogia A. IsolatedExtranodal Natural Killer T-Cell Lymphoma of the Orbit in a Young Patient: Complete Regression with the SMILE Regimen.OculOncolPathol. 2017 Jan;3(1):45-48.

• RAMT, KakkanattuTJ, KumarA, Gogia A. WigN. A Case of Idiopathic CD4 Lymphocytopenia (ICL): Immunological Mystery Leading to Storm of Diseases.Journal of Clinical & Diagnostic Research.2017; 11(12)

• SVDeo S, Shukla NK, Gogia A. DN SharmaAJakhetiya, DK Muduly. A comparative study of clinical profile and relapse patterns in triple-negative and non-triple-negative breast cancer patients treated with curative intent. Indian Journal of Surgical Oncology.2017; 8(3), 291-297

• Vallonthaiel AG, Kaushal S, Gogia A. Mathur SR.Bilateral Myeloid Sarcoma of Breast in a Young Male Occurring after 11 Years of Chronic Myeloid Leukemia Diagnosis: A Unique Pattern of Relapse.Breast J. 2016 Nov;22(6):692-693.

• Rani L, Mathur N, Gogia A.Vishnubhatla S, Kumar L, Sharma A, Dube D, Kaur P, Gupta R.Immunoglobulin heavy chain variable region gene repertoire and B-cell receptor stereotypes in Indian patients with chronic lymphocytic leukemia.Leuk Lymphoma. 2016 Oct;57(10):2389-400

• Gupta VG, Gogia A. DDGP versus SMILE in NK/T-Cell Lymphoma-Letter.Clin Cancer Res. 2016 Aug 15;22(16):4271

• Garg PK, Deo SV, Kumar R, Shukla NK, Thulkar S, Gogia A.Sharma DN, MathurSR.Staging PET-CT Scanning Provides Superior Detection of Lymph Nodes and Distant Metastases than Traditional Imaging in Locally Advanced Breast Cancer.World J Surg. 2016 Aug;40(8):2036-42.

• Ramteke P, Seenu V, Prashad R, Gupta SD, Iyer V, Deo S, Gogia A. Mathur S.Alteration in steroid hormone and Her-2/neu receptor status following neoadjuvant chemotherapy in locally advanced breast cancer: Experience at a tertiary care centre in India.Indian J Cancer. 2016 Jul-Sep;53(3):366-371.

• Reddy R, Gogia A. Kumar L, Sharma A, Bakhshi S, Sharma MC, Mallick S, Sahoo R.HIV-associated hematologic malignancies: Experience from a Tertiary Cancer Center in India.Indian J Med Paediatric Oncol. 2016 Jul-Sep;37(3):141-5.

• Pramanik R, Sahoo RK, Gogia A. Neutropenia due to palbociclib: A word of caution? . Indian J Med PaediatrOncol. 2016 Jul-Sep;37(3):206

• Chopra A, Soni S, Pati H, Kumar D, Diwedi R, Verma D, Vishwakama G, Bakhshi S, Kumar S, Gogia A. Kumar R.Nucleophosmin mutation analysis in acute myeloid leukaemia: Immunohistochemistry as a surrogate for molecular techniques.Indian J Med Res. 2016 Jun;143(6):763-768

• Chharchhodawala T, Gajendra S, Tiwari P, Gogia A. Gupta R.Therapy Related Acute Myeloid Leukemia with t(8;16) Mimicking Acute PromyelocyticLeukemia.Indian J Hematol Blood Transfus. 2016 Jun;32(Suppl 1):20-2

• Roy S, Madan R, Gogia A. Tripathy K, Sharma D, Julka PK, RathGK.Short course palliative radiotherapy in the management of choroidal metastasis: An effective technique since ages.J Egypt NatlCanc Inst. 2016 Mar;28(1):49-53

• Mukherjee A, Agarwal KK, Gogia A. Bal C, Kumar R.Bilateral Renal Involvement in Mantle Cell Lymphoma on FDG PET/CT.ClinNucl Med. 2016 Apr;41(4):

• Chopra A, Soni S, Verma D, Kumar D, Dwivedi R, Vishwanathan A, Vishwakama G, Bakhshi S, Seth R, Gogia A. Kumar L, Kumar R.Prevalence of common fusion transcripts in acute lymphoblastic leukemia: A report of 304 cases.Asia Pac J ClinOncol. 2015 Dec;11(4):293-8.

• Kakkar A, Rajeshwari M, Bhethanabhotla S, Kaur K, Jain D Gogia A. Ray R, Seth A.Primary diffuse large B-cell lymphoma of the prostate: A report of two cases with diagnostic considerations.J Cancer Res Ther. 2015 Oct-Dec;11(4):977-9.

• Gogia A. Raina V, Deo SV, Shukla NK, Mohanti BK Male breast cancer: A single institute experience.Indian J Cancer. 2015 Oct-Dec;52(4):526-9

• Gogia A. Iqbal N, Sharma MC, RainaV.Isolated Richter's transformation of brain parenchyma: Remission with DeAngelisprotocol.Indian J Cancer. 2015 Jul-Sep;52(3):329-30.

• Iqbal S, Vishnubhatla S, Raina V, Sharma S Gogia A. .Deo SS, Mathur S, ShuklaNK.Circulating cell-free DNA and its integrity as a prognostic marker for breast cancer.Springerplus. 2015 Jun 17;4:265.

• Mallik N, Chopra A, Jha A, Gogia A. Kumar R.Development of myelodysplastic syndrome in a patient with chronic myelogenousleukemia treated with imatinib.Leuk Lymphoma. 2015 Apr;56(4):1143-4.

• Gogia A. Sharma A, Raina V, Chopra A.Superior vena cava syndrome: Initial presentation of acute myeloid leukemia in a child.Indian J Cancer. 2015 Jan-Mar;52(1):21

• Sahai P, Baghmar S, Nath D, Arora S, Bhasker S, Gogia A. Sikka K, Kumar R, Chander S.Extrapulmonary Small Cell Carcinoma - a Case Series of Oropharyngeal and Esophageal Primary Sites Treated with Chemo-Radiotherapy.Asian Pac J Cancer Prev. 2015;16(16):7025-9.

• Gogia A. Raina V, Gupta R, Gajendra S, Kumar L, Sharma A, Kumar R, VishnubhatlaS.Prognostic and predictive significance of smudge cell percentage on routine blood smear in chronic lymphocytic leukemia.Clin Lymphoma Myeloma Leuk. 2014 Dec;14(6):514-7.

• Gogia A. Mehta P, Pramanik R, Gupta R.Chronic lymphocytic leukemia with massive ascites: An unusual presenting manifestation.South Asian J Cancer. 2014 Oct;3(4):235-6.

• Gogia A. Raina V, Deo SV, Shukla NK, MohantiBK.Young breast cancer: A single centerexperience.Indian J Cancer. 2014 Oct-Dec;51(4):604-8

• Gajendra S, Gogia A. Das P, Gupta R, Tanwar P.Acute myeloid leukemia presenting as "bowel upset": a case report.JClinDiagn Res. 2014 Jul;8(7):FD09-10

• Gogia A. Raina V, Kumar L, Sharma A, Mehta P, Sharma MC.Diffuse large B-cell lymphoma in patients with chronic lymphocytic leukemia: A single centerexperience.South Asian J Cancer. 2014 Jul;3(3):186.

• Gogia A. Deo SV, Shukla NK, Mohanti BK, RainaV.Pregnancy associated breast cancer: an institutional experience.Indian J Cancer. 2014 Apr-Jun;51(2):167-9.

• Gogia A. Raina V, Deo SV, Shukla NK, Mohanti BK Triple-negative breast cancer: An institutional analysis.Indian J Cancer. 2014 Apr-Jun;51(2):163-6.

• Gogia A. Mehta P, Pramanik R, Kumar R.Isolated breast relapse mimicking breast cancer in elderly patient with acute lymphoblastic leukemia.Turk J Haematol. 2014 Jun;31(2):203-4

• Gogia A. Khurana S, ParamanikR.Acute myocardial infarction after first dose of rituximab infusion.TurkJHaematol. 2014 Mar;31(1):95-6. doi: 10.4274/Tjh.2013.0247

• Chopra A, Bakhshi S, Pramanik SK, Pandey RM, Singh S, Gajendra S, Gogia A. Chandramohan J, Sharma A, Kumar L, Seth R, Rai S, Kumar R.Immunophenotypic analysis of T-acute lymphoblastic leukemia.A CD5-based ETP-ALL perspective of non-ETP T-ALL.Eur J Haematol. 2014 Mar;92(3):211-8.

• Gogia A. Singh L, Karak AK, BakhshiS.Primarytonsillar Ewing sarcoma in young adult: A rare tumor at an uncommon site.Indian J Med PaediatrOncol. 2014 Jan;35(1):122-3.

• Gogia A. Raina V, Iqbal N, Murugan V.Spontaneoustumorlysis syndrome in a patient of chronic lymphocytic leukemia.Indian J Med PaediatrOncol. 2014 Jan;35(1):120

• Gogia A. Raina V, Deo SV, Shukla NK, Mohanti BK, Sharma DN.Inflammatory breast cancer: a single centre analysis.Asian Pac J Cancer Prev. 2014;15(7):3207-10.

• Gogia A. Raina V, Deo SV, Shukla NK, Mohanti BK, Sharma DN. Taxane and anthracycline based neoadjuvant chemotherapy for locally advanced breast cancer: institutional experience.Asian Pac J Cancer Prev. 2014;15(5):1989-92.

• Gogia A. Bansal A, Suri V, BakhshiS.Childhood orbital soft tissue sarcoma in xerodermapigmentosum with good tolerance to chemotherapy and radiotherapy.Pediatr Blood Cancer. 2013 Dec;60(12):2093-4.

• Gogia A. Sharma A, Raina V, Kumar L, Gupta R, Kumar R.Prevalence ofZAP-70 and CD 38 in Indian chronic lymphocytic leukemiapatients.Indian J Cancer. 2013 Oct-Dec;50(4):333-6.

• Gogia A. Sharma MC, BakhshiS. Subcutaneous nodules as initial presentation of Burkitt lymphoma in HIV-negative child.JPediatrHematolOncol. 2013 Nov;35(8):e326-8

• Gogia A. Raina V, Gupta R.Disseminated tuberculosis mimicking relapse in hairy cell leukemia.Indian J Cancer. 2013 Oct-Dec;50(4):321.

• Gogia A. Mehta P, Raina V.Cryptococcal meningitis in chronic lymphocytic leukemia.Indian J Cancer. 2013 Oct-Dec;50(4):301.

• Gogia A. Raina V, Gupta R.Massive ascites as an presenting feature of plasma cell leukemia.Indian J Cancer. 2013 Oct-Dec;50(4):301.

• Gogia A. Sharma A, Chopra A, Kumar R Mediastinal granulocytic sarcoma: poor risk AML?.J Indian Med Assoc. 2013 Aug;111(8):562.

• Gajendra S, Gogia A. Tanwar P, Sahoo MK, Bhethanabhotla S, Durgapal P, Gupta R.Synchronous metastatic pulmonary adenocarcinoma with small cell lymphoma.Leuk Lymphoma. 2014 Jul;55(7):1678-80.

• Gogia A. Pushker N, Sen S, Bakhshi S. Avoidance of exenteration in orbital sebaceous gland carcinoma with neoadjuvantchemotherapy.Graefes Arch ClinExpOphthalmol. 2013 Oct;251(10):2479-80. doi: 10.1007/s00417-013-2382-8. Epub 2013 May 25. No abstract available.

• Gogia A. Pathania S, Das P, Gupta YK, Bakhshi S.Methotrexate-induced toxic epidermal necrolysis in a child.Indian J Dermatol. 2013 Mar;58(2):161.

• Gogia A. Sharawat SK, Kumar R, Sarkar C, BakhshiS.Systemicmastocytosis associated with childhood acute myeloid leukemia.JPediatrHematolOncol. 2013 Mar;35(2):163-4.

• Gogia A.Sharma A, Raina V, Kumar L, Vishnubhatla S, Gupta R, Kumar R.Assessment of 285 cases of chronic lymphocytic leukemia seen at single large tertiary center in Northern India.Leuk Lymphoma. 2012 Oct;53(10):1961-5

• Gogia A.Sharma A, Raina V, Gupta R.Priapism as an initial presentation of chronic lymphocytic leukemia.Leuk Lymphoma. 2012 Aug;53(8):1638-9. doi: 10.3109/10428194.2012.656636.

• Mishra J, Chopra A, Gogia A.Kumar R.Seemingly insignificant, but crucial morphological leads in the diagnosis of non-secretory multiple myeloma in an adolescent.Indian J PatholMicrobiol. 2012 Jan-Mar;55(1):130-2

• Gajendra S, Gupta R, Sharma A, Gupta R,Gogia A.Acute myeloid leukaemia with Pseudo-Chediak-Higashi granules and intracytoplasmicvacuoles.Eur J Haematol. 2011 Jun 16. doi: 10.1111/j.1600-0609.2011.01668.

• Gogia A.Thulkar S, Sahoo R, BakhshiS.Intramedullary spinal cord hemorrhage in childhood acute lymphoblastic leukemia following lumbar puncture.Pediatr Blood Cancer. 2011 Feb;56(2):329-30

• Gogia A. Mishra J, Kumar R, BakhshiS.Nonsecretory myeloma in a child.Pediatr Blood Cancer. 2011 Feb;56(2):321-2. doi: 10.1002/pbc.22812

• Kumar L, Ganessan P, Ghosh I, Panda D, Gogia A. MandhaniaS.Autologous blood stem cell transplantation for Hodgkin and non-Hodgkin lymphoma: complications and outcome.Natl Med J India. 2010 Nov-Dec;23(6):330-5.

• Gogia A. BakhshiS.Plasmablastic lymphoma of oral cavity in a HIV-negative child.Pediatr Blood Cancer. 2010 Aug;55(2):390-1.

• Ganesan P, Sharma A, Mohanti BK, Gogia A..Protracted cisplatin-induced vomiting responding to mosapride.Indian J Cancer. 2010 Jan-Mar;47(1):73-4.

• AG Vallonthaiel, S Kaushal, Gogia A. S R. Mathur. Bilateral Myeloid Sarcoma of Breast in a Young Male Occurring after 11 Years of Chronic Myeloid Leukemia Diagnosis: A Unique Pattern of Relapse. The Breast Journal.2016; 22(6), 692-693

• Gogia A. Nath D. T Cell Lymphoma: A Rough Road to Diagnosis. American Journal of Cancer Case Reports. 2015; 3 (3), 177-181

• Gogia A. Mehta P, Pramanik R, Gupta R. Chronic lymphocytic leukemia with massive ascites: An unusual presenting manifestation. South Asian J Cancer. 2014 Oct;3(4):235-6.

• Attili VS, Singh VP, Sundar S, Mehta H, Negi ML, Gogia A. Raju SH, Rai M. Malignantmyelomatous pleural effusion with good response to combination chemotherapy. J Assoc Physicians India. 2007 Aug;55:595-6.

• Gogia A. Aggarwal N, Jayaswal A. Angiosarcoma of spine .Indian Journal of Medical and Paediatric Oncology 2006; 27 (3), 40.

• Mehata H, Gogia A. et al. A case of post bee sting encephalitis. African Journal of Neurological Sciences. 2006;25:69-72

Recently accepoted

• A Mishra, AS Oberoi, S Deo, J Sharma, A.Gogia, DN Sharma, S Mathur, Bilateral Breast Cancer: Clinical Profile and Management Indian Journal of Surgical Oncology 2023 , 1-8

 

POSTER / ORAL PRESENTATION – abstracts

• MB BM, akashkumar, A Batra, V Sharma, B Kataria, A.Gogia, S Mathur,Metformin with neoadjuvant chemotherapy in localized triple negative and HER2neu-positive breast cancer: A prospective phase 2 open label randomised controlled trial (McBETH)....Journal of Clinical Oncology 41 (2023) (16_suppl), TPS631-TPS631.

• R Pramanik, S Vats, S Mitra, SVS Deo, L Kumar, A.Gogia, S Khurana, Assessment of Knowledge and Attitude of Breast and Ovarian Cancer Patients Regarding Hereditary Breast-Ovarian Cancer Syndrome at a Tertiary Cancer Institute: A Cross-Sectional … Indian Journal of Medical and Paediatric Oncology (2023).

• A.Gogia, S Kumar, A Sharma, S Mallick, R Gupta, : IBCL-188 Hairy Cell Leukemia: A Single Center Analysis from India Clinical Lymphoma Myeloma and Leukemia (2023), S449

• R Thakur, S Deo, AS Oberoi, S Bhoriwal, D Sharma, A.Gogia, U Dasgupta, Role of lipidomic signatures in prognostication of breast cancer-A pilot study European Journal of Surgical Oncology 49 (5), 2023 e230

• A Mishra, SVS Deo, A.Gogia, S Mathur, J Sharma, J Josiphen148P Pattern of axillary lymph node involvement and scope of post neoadjuvant chemotherapy sentinel lymph node biopsy among breast cancer patients in developing countriesESMO Open 8 2023 (1)

• A Mishra, SVS Deo, A.Gogia, B Bansal, S Bhoriwal, 176P Awareness & knowledge pertaining to genetic breast cancer in developing countries: A questionnaire based prospective study of 300 patientsESMO Open 8 (1) 2023

• AS Oberoi , SVS Deo , S Bhoriwal , DN Sharma , A.Gogia. , S Mathur et al Lipidomics in breast cancerEuropean Journal of Surgical Oncology 49 (5), 2023 e239

• R Kumar, U Agrawal, S Deo, SR Mathur, A.Gogia,P Tanwar, :- Comprehensive mutation profiling of PIK3CA gene in Indian breast cancer patients European Journal of Cancer 175, S33 (2023)

• A.Gogia, S Kirar, A Sharma, A Agni, S Mallick, R Gupta,ABCL-165 Primary Testicular Diffuse Large B-Cell Lymphoma: Outcome With Uniform Treatment Protocol Clinical Lymphoma Myeloma and Leukemia (2023), S421

• A.Gogia, A Santosh, S Mallick, R Gupta,: ABCL-190 Primary Cutaneous Non-Hodgkin Lymphoma-Leg Type: Long-Term Durable Response With Dose-Adjusted EPOCH-R RegimenClinical Lymphoma Myeloma and Leukemia (2023), S425-S426

• A.GogiaS Kirar, A Sharma, A Agni, S Mallick, R Gupta, POSTER: ABCL-165 Primary Testicular Diffuse Large B-Cell Lymphoma: Outcome With Uniform Treatment Protocol Clinical Lymphoma Myeloma and Leukemia (2023), S200

• A.Gogia, Kirar S, Sharma A, Gupta A, Mallick S,ABCL-167 HIV-Associated Diffuse Large B-Cell Lymphoma: Outcome With Uniform DA-EPOCH-R Protocol Clinical Lymphoma Myeloma and Leukemia (2023), S421.

• A Chaudhary, A Sharma, A.Gogia, PS Malik, A Batra, akashkumar, :Sexual health among cancer patients on active chemotherapy: A cross-sectional study from tertiary care cancer center in India. Journal of Clinical Oncology 41 (2023)(16_suppl), e24224-e24224

• N SG, A.Gogia, R Pramanik, HKR Sagiraju, SVS Deo, DN Sharma, :- Survival outcomes of BRCA1/BRCA2 mutated breast cancers: Study from a tertiary care cancer centre in India.Journal of Clinical Oncology 41 (16_suppl) (2023), e22546-e22546

• A Batra, A Sharma, S Bakhshi, A.Gogia R Pramanik, S Khurana, :- Assessing the feasibility of recording smartphone-based patient-reported outcomes in patients with cancer: A pilot study.Journal of Clinical Oncology 41 (2023)(16_suppl), e13528-e13528

• A.Gogia, N SG, R Pramanik, R Gupta, SVS Deo, S Mathur, D Sharma, :-Prevalence of BRCA1 and BRCA2 mutations in an unselected cohort of Indian women with breast cancer. Journal of Clinical Oncology 41 (2023).(16_suppl), e13004-e13004.

• A.GogiaN SG, S Mathur, SVS Deo, S Ganguly, A Batra, D Sharma, :- Prevalence of low HER2 expression in breast cancer patients: An Indian experience. Journal of Clinical Oncology 41 (2023)(16_suppl), e12543-e12543

• A.Gogia, A Santosh, S Mallick, R Gupta,POSTER: ABCL-190 Primary Cutaneous Non-Hodgkin Lymphoma-Leg Type: Long-Term Durable Response With Dose-Adjusted EPOCH-R RegimenClinical Lymphoma Myeloma and Leukemia (2023), S207

• A.Gogia, S Kumar, A Sharma, S Mallick, R Gupta,POSTER: ABCL-189 The Spectrum of HIV-Associated Hematological Malignancies at a Tertiary Care Centre in North IndiaClinical Lymphoma Myeloma and Leukemia (2023), S200

• A.Gogia, S Kumar, A Sharma, S Mallick, R Gupta, ABCL-189 The Spectrum of HIV-Associated Hematological Malignancies at a Tertiary Care Centre in North India Clinical Lymphoma Myeloma and Leukemia (2023), S425

• S Ganguly, A.Gogia, Tumor-infiltrating lymphocyte therapy versus ipilimumab in advanced melanomaCancer Research, Statistics, and Treatment 6 (1) (2023), 173-174.

• AP Santhosh, A.Gogia, Rezvilutamide in metastatic, hormone-sensitive prostate cancerCancer Research, Statistics, and Treatment 6 (1) (2023), 172-173.Kumar R, Srivastava A, Agrawal U, Deo SV, Mathur SR, A.Gogia, Tanwar P. Evaluation of mutation profile of oncogenic signalling pathway in breast cancer among Indian population. Cancer Research. 2022 Jun 15;82(12_Supplement):2277.

• A.Gogia, S Nair, S Kumar, A Sharma, A Biswas, S Mallik, R GuptaPoster : ABCL-200 Primary and Secondary Extranodal Diffuse Large B-Cell Lymphoma: A Single-Center Survey from India Clinical Lymphoma, Myeloma and Leukemia (2022).S167

• I Gupta, MR Lone, P Ramteke, A.Gogia, A Upadhyay, S Mallick, :Poster: ABCL-523 Immunohistochemical (IHC) Expression of Epigenetic Regulators (EZH-2 and H3K27) as well as Cell Cycle Regulators (P16, P53 and RB) in Patients Diagnosed With … Clinical Lymphoma, Myeloma and Leukemia (2022), S170

• R Kumar, A Srivastava, U Agrawal, SVS Deo, SR Mathur, A.Gogia... Evaluation of mutation profile of oncogenic signalling pathway in breast cancer among Indian population Cancer Research 82 (2022) (12_Supplement), 2277-2277

• B Chaudhary, A Mahalik, P Kumar, M Tripathi, A.Gogia, R Kumar, CS BalInitial experience of fully automated radiosynthesis and biodistribution of ¹⁸F-FESIndian Journal of Nuclear Medicine 37 (2022)(5, suppl. 1), S47-S48.

• Deo SVS, Chhebbi M, Mishra A, Sharma J, Gogia. A, Pramanik R:- A Review of Surgical Perspectives of Breast Cancer Genetics and Risk-Reducing Surgery Indian Journal of Surgery 84 (Suppl 3), 605-610 (2022)

• I Gupta, MR Lone, P Ramteke, A.Gogia Upadhyay, S Mallick Poster: ABCL-523 Immunohistochemical (IHC) Expression of Epigenetic Regulators (EZH-2 and H3K27) as well as Cell Cycle Regulators (P16, P53 and RB) Clinical Lymphoma, Myeloma and Leukemia 2022, S170

• I Gupta, MR Lone, P Ramteke, A.Gogia, A Upadhyay, S Mallick, ABCL-523 Immunohistochemical (IHC) Expression of Epigenetic Regulators (EZH-2 and H3K27) as well as Cell Cycle Regulators (P16, P53 and RBClinical Lymphoma Myeloma and Leukemia 2022, S382

• A.Gogia, R Gupta, L Kumar, A Sharma, L Rani, S MallickIBCL-429 Prevalence of B-Cell Chronic Lymphoproliferative Disorders at a Large Tertiary Care Center in IndiaClinical Lymphoma Myeloma and Leukemia 2022, S392

• Bharath BG, A.Gogia. Smart start: It really is SMART!Cancer Research, Statistics, and Treatment 5 (4), 795-796 (2022)

• Jain S , Mandal T,Ramteke P, Sharma MC, A. Gogia, M Aggarwal, ...Poster: TCL-306 Application of the Proposed Immunohistochemistry Algorithm for the Prognostication of GATA3 and TBX21 Subtypes of Peripheral T-Cell Lymphoma, Not Otherwise …Clinical Lymphoma, Myeloma and Leukemia (2022), S176

• J Ghosh, C Das, A.Gogia, G Biswas, C Desai, S Rajpurohit, P Mehta, ...EP216/# 881 Safety and tolerability of olaparib in Indian patients with ovarian cancer: the prospective, single-arm, phase 4 soli trial International Journal of Gynecologic Cancer (2022) 32 (Suppl 3)

• Gupta A, A.Gogia, Sagiraju HK, Deo SV, Gupta R, Mathur S, Sharma D. A real-world experience of TCH (docetaxel/carboplatin/trastuzumab) regimen in early, locally advanced and oligometastatic HER2 positive breast cancer from tertiary care center in North India. J Clin Oncol 2022;40:e12505-e12505 .

• A.Gogia, Gupta A, Deo SV, Sharma D, Mathur S. Safety, efficacy and survival outcome of Ado-trastuzumab emtansine (T-DM1) in patients with metastatic HER2-positive breast cancer: An Indian experience. J Clin Oncol 2022;40:e13008-e13008.

• Sharma RK, A.Gogia, Sagiraju HK, Deo SS, Sharma D, Mathur S. Impact of capecitabine maintenance on survival outcomes in triple-negative breast cancer patients not attaining pathological complete response following neoadjuvant chemotherapy: Real-world data from a tertiary care center from India. J Clin Oncol 2022;40:e12593-e12593.

• Batra A, kumar A, Pramanik R, Khurana S, Pushpam D, Bakhshi S, Sharma A, A.Gogia, Malik PS. Physical and psychological symptom burden in patients newly diagnosed with solid organ cancers in a tertiary care centre in India. J Clin Oncol 2022;40:e24081-e24081.

• Sagiraju HK, A.Gogia, Sharma RK, Deo SV, Sharma D, Gupta R, Mathur S. Association of pre-treatment hemoglobin levels with survival outcomes among Indian women with triple negative breast cancer. J Clin Oncol 2022;40:e12549-e12549

• Gupta A, A.Gogia, Sagiraju HK, Deo SV, Sharma D, Mathur S, Gupta R. Outcomes of neoadjuvant combination chemotherapy with and without targeted therapy in HER2-positive breast cancer: A real-world experience from tertiary care center in North India. J Clin Oncol 2022;40:e12601-e12601 .

• A.Gogia, Sharma A, Gupta R, Rani L, Mallick S. Safety and efficacy of Ibrutinib in Indian patients with chronic lymphocytic leukemia. J Clin Oncol 2022;40:e19585-e19585

• Das N, Gupta R, Dahiya M, Rai S, Singh S, Sahoo RK, A.Gogia, Sharma A, Kumar L. MM-359: Pattern-Based Identification of Normal and Aberrant Plasma Cell Compartment across a Spectrum of Plasma Cell Proliferative Disorders Using Multiparametric Flow Cytometry. Clinical Lymphoma Myeloma and Leukemia. 2021 Sep 1;21:S438.

• S Jain, A Goswami, T Mandal, MR Lone, P Ramteke, MC Sharma A.Gogia....Poster: TCL-239: Clinical, Pathological, and Prognostic Implications of RHOAG17V Mutation in Peripheral T-Cell Lymphomas Clinical Lymphoma Myeloma and Leukemia 2021, S248

• DN Sharma, SVS Deo, S Bhoriwal, Y Izzuddeen, A Binjola, A. Gogia :-MSPP04 Presentation Time: 4: 30 PM: Interstitial Brachytherapy Based Accelerated Partial Breast Irradiation After Oncoplastic Breast Conserving SurgeryBrachytherapy 2021 (6), S36

• N Das, R Gupta, M Dahiya, S Rai, S Singh, RK Sahoo, A.Gogia, A Sharma, ... MM-359: Pattern-Based Identification of Normal and Aberrant Plasma Cell Compartment across a Spectrum of Plasma Cell Proliferative Disorders Using Multiparametric Flow Cytometry Clinical Lymphoma Myeloma and Leukemia 2021, S438

• A.Gogia, S Chellapuram, A Sharma, S Mallick, R Gupta, ABCL-064:“DA-EPOCH+/-R” Protocol in High-Grade Lymphoma: An AnalysisClinical Lymphoma Myeloma and Leukemia 2021 , S379-S380

• R Gupta, N Das, M Dahiya, S Rai, S Singh, VK Prajapati, A.Gogia...MM-329: Evaluation of Immunophenotype of the Non-Neoplastic Plasma Cell Compartment and Post-Therapy Immunomodulation to Understand Nuances in MRD Assessment of Multiple …Clinical Lymphoma Myeloma and Leukemia 2021, S436-S437

• P Ramteke, S Jain, S Meena, T Mandal, P Das, R Yadav, MC Sharma, A. Gogia:- ...Poster: ABCL-321: Clinicopathological Profile of Gastrointestinal Lymphoma Diagnosed Over a Period of 6-Years: A Tertiary Care Center ExperienceClinical Lymphoma Myeloma and Leukemia 2021, S242

• A. Gogia, Kumar L, Sharma A, Mallick S, Gupta R, Rani L. CLL-069: Incidence of Second Cancer in Patients with Chronic Lymphocytic Leukemia: The Indian Scenario. Clinical Lymphoma, Myeloma and Leukemia. 2021 Sep 1;21:S316-7.

• Jain S, Goswami A, Mandal T, Lone MR, Ramteke P, Sharma MC, A. Gogia , Sharma A, Aggarwal M, Sahoo R, Bakhshi S. TCL-239: Clinical, Pathological, and Prognostic Implications of RHOAG17V Mutation in Peripheral T-Cell Lymphomas. Clinical Lymphoma, Myeloma and Leukemia. 2021 Sep 1;21:S413-4.

• Sharma RK, A. Gogia Deo SV, Sharma D, Mathur S, Sagiraju HK. Does pathological complete remission after neoadjuvant chemotherapy translate to longer relapse-free survival in patients with triple-negative breast cancer in the Indian population? J Clin Oncol. 2021;39:e12618-e12618.

• Sagiraju HK, A. Gogia Sharma D, Deo SV, Mathur S. Survival outcomes of breast cancer patients with brain metastases: Single center experience from Northern India. J Clin Oncol. 2021 39:15_suppl, e13003-e13003

• A. Gogia Arora S, Choudhary P, Kumar R, Thulkar S, Deo SV, Sharma D, Bhatnagar S. Real-world Indian scenario of CDK4/6 inhibitors (palbociclib and ribociclib) with endocrine therapy in upfront hormone positive metastatic breast cancer. J Clin Oncol 2021 39:15_suppl, e13028-e13028.

• A. Gogia, Arora S, Deo SV, Mathur S, Sharma D. Efficacy and safety of neoadjuvantdocetaxel, carboplatin, trastuzumab, and pertuzumab (TCH-P) in HER2-positive breast cancer: An Indian experience. J Clin Oncol. 2021 39:15_suppl, e12619-e12619 Sharma RK, A.GOGIAGupta R, Deo SV, Sharma D, Mathur S, Sagiraju HK. Impact of pre-treatment derived neutrophil-lymphocyte-ratio on outcomes in patients with triple- negative breast cancer. J Clin Oncol 2021 39:15_suppl, e12556-e12556.

• Atul Batra, Akhil P. Santosh, Raja Pramanik, A. Gogia, R. M. Pandey, akashkumar, Atul SharmaRandomized double-blind, placebo-controlled study of topical diclofenac in prevention of hand-foot syndrome in patients receiving capecitabine. (ASCO 2021) J Clin Oncol 39, 2021 (suppl 15; abstr TPS12135)

• Rakesh Kumar Sharma, A. Gogia, SVS Deo, Dayanand Sharma, Sandeep Mathur, Hari Krishna Raju Sagiraju;Impact of pre-treatment derived neutrophil-lymphocyte-ratio on outcomes in patients with triple-negative breast cancer. J Clin Oncol 39, 2021 (suppl 15; abstr e13010)

• K Raghuram, SVS Deo, A. Gogia, S Thulkar, E Dhamija, DN Sharma, Analysis of surgical and oncological outcomes of breast conservation surgery following neo adjuvant chemotherapy in locally advanced breast cancer. European Journal of Surgical Oncology 46 2021(6), e31

• SC Nair, A. Gogia, L Kumar, A Sharma, A Biswas, S Mallick :-Clinicopathological features and outcome of diffuse large B-cell lymphoma patients treated in a resource-limited setting.Journal of Clinical Oncology 38 (15_suppl), e20062-e20062

• A. Gogia, S Nair, A Sharma, L Kumar, S Mallick, A Biswas, R Gupta Non-Hodgkin lymphoma: The Indian scene. Journal of Clinical Oncology 38 (15_suppl), e20063-e20063

• A. Gogia, S Deo, D Sharma, S Mathur. Breast cancer: The Indian scenario.Journal of Clinical Oncology 38 (15_suppl), e12567-e12567

• SC Nair, A. Gogia, L Kumar, A Sharma, A Biswas, S Mallick Clinicopathologic features and outcome of extra-nodal diffuse large B-cell lymphoma: An institutional experience from North India.Journal of Clinical Oncology 38 (15_suppl), e20079-e20079

• P Choudhary, A. Gogia, S Deo, S Mathur, D Sharma. Neoadjuvant chemotherapy in locally advanced breast cancer: Clinicopathological characteristics and correlation with pathological complete response.Journal of Clinical Oncology 38 (15_suppl), e12658-e12658

• R Gupta, L Rani, G Kaur, S Khan, A. Gogia ,A Gupta, A Sharma, L KumarmiR-223 and miR-551a as gene signatures of aggressive chronic lymphocytic leukemia. Leukemia& Lymphoma 61, 206-207

• S Mathur, A Johnson, SVS Deo, A. Gogia, S Kahol, D Jain, V IyerPDL1 Expression and Tumour Infiltrating Lymphocytes in Triple-Negative Breast Cancer and its Correlation with Clinicopathological Features and Response to ChemotherapyLaboratory Investigation 100 (Suppl 1), 208-209

• H Natarajan, L Kumar, S Bakhshi, A Sharma, T Velpandian, M Kabra, A. Gogia Imatinib induced toxicity and its influence on cytogenetic and molecular response in newly diagnosed patients with chronic myeloid leukemia Annals of Oncology 201930 (Supplement_9), mdz427. 004

• A. Gogia L Kumar, A Sharma, R Gupta, L Rani. Incidence and outcome of chronic lymphocytic leukemia with deletion 17p: An Indian experience; challenges and opportunities. Annals of Oncology 30 (Supplement_5), mdz269. 055

• N Das, A Malhotra, R Gupta, S Rai, SK Gupta, RK Sahoo, A. GogiaCD123 is an Important Predictor of Post Induction Response and Early Treatment Outcome in Acute Lymphoblastic Leukemia. Clinical Lymphoma, Myeloma and Leukemia 19, S197

• S Mallick, A Panda, MR Lone, A Goswami, P Ramteke, MC Sharma, A. GogiaClinicopathologicalProfileof Primary Double Expressor Lymphoma. Clinical Lymphoma, Myeloma and Leukemia 19, S257

• N Das, A Malhotra, R Gupta, S Rai, S Singh, RK Sahoo, A. Gogia.Role of CD123 as Determinant of Minimal Residual Disease in Acute Myeloid Leukemia. Clinical Lymphoma, Myeloma and Leukemia 19, S235

• A. Gogia, R Gupta, A Sharma, L Kumar, V Raina, L Rani. Chronic lymphocytic leukemia: An Indian experience. Journal of Clinical Oncology 37 (15_suppl), e19007-e19007 2019

• KR Soti, L Kumar, R Saxena, S Bakhshi, A. Gogia, PS Malik, R Sahoo. Characteristics and outcomes of Philadelphia chromosome-negative myeloproliferative neoplasm in a tertiary institute in India: An ambispective study. Journal of Clinical Oncology 37 (15_suppl), e18553-e185532019

• M Sharma, A. Gogia SVS Deo, NK Shukla, S Thulkar, R Kumar, D SharmaProfile of metastatic breast carcinoma: Single center experience from a developing country. Journal of Clinical Oncology 36 (15_suppl), e13102-e13102……2018

• M Sharma, A. Gogia SVS Deo, NK Shukla, D Sharma, S Thulkar, R KumarEstrogen receptor (ER), progesterone receptor (PR) and Her2neu receptor expresssion: Change from baseline to first metastasis in breast cancer—Single center experience from … Journal of Clinical Oncology 36 (15_suppl), e13095-e1309, 2018

• SK Paikaray, A. Gogia L Kumar, A Sharma, A Biswas, MC SharmaA phase III open label randomized study to compare the efficacy of lenalidomide-rituximab vs bendamustine-rituximab in treatment naive follicular lymphoma. Journal of Clinical Oncology 36 (15_suppl), e19552-e19552…….2018

• A Biswas, L Kashyap, N Adhikari, A. Gogia, R Sahoo, A Sharma. Secondary central nervous system lymphoma clinical experience from a regional cancer centre in India. Radiotherapy and Oncology 127, S692…2018

• L Rani, M Dahiya, N Mathur, R Gupta, A. Gogia, L Kumar, A Sharma.Detection of genetic aberrations in CLL using multiplex ligation-dependent probe amplification (MLPA).Leukemia & Lymphoma 58, 176-177..2017

• SVS Deo, NK Shukla, A. GogiaBilateral Breast Cancer-Incidence, Clinical Spectrum And Challenges In The Management.. Journal of Cancer Research & Therapeutics 13. 2017

• SVS Deo, NK Shukla, A. Gogia, Criteria For Pathological Complete Response (Pcr) Cr And Its Impact On Relapse Rates In Breast Cancer Patients Undergoing Neo-Adjuvant Chemotherapy- Journal of Cancer Research & Therapeutics 13. 2017

• L Rani, R Gupta, N Mathur, K Singh, A. Gogia, D Sundar, L Kumar,Elucidation of miRNAs associated with disease progression and response in chronic lymphocytic leukemia, et.al. LEUKEMIA & LYMPHOMA 58, 173-174….2017

• A Jakhetiya, SS Deo, NK Shukla, A. Gogia D Sharma, D Muduly, S Mathur ,Patterns of Loco-Regional Relapse in Curatively Treated Locally Advanced Breast Cancer (LABC) Patients: A Single Centre Retrospective Study. et.al. Annals Of Surgical Oncology 24, S50-S50…2017

• VG Gupta, A. GogiaP Mehta, L Kumar, A Sharma, S Bakhshi, S Thulkar.Early stage natural killer/T cell lymphoma with local tumor invasiveness treated with a uniform SMILE protocol: An institutional study from India. Annals of Oncology 27 (suppl_9)..2016

• S Bhoriwal, S Deo, R Kumar, NK Shukla, S Thulkar, A. Gogia DN Sharma,A prospective study comparing conventional investigation and PET-CT scan for staging in locally advanced breast carcinoma. et.al. European journal of Surgical Oncology Volume 42,Issue 42, Issue 9, Pages S138

• CK Das, L Kumar, A. Gogia R Kaushal.Bone marrow involvement in mantle cell lymphoma: An immunophenotyping analysis with clinicopathologic correlation from a tertiary care center in North India.European Journal of Surgical Oncology 42 (9), S138..2016

• S Taywade, R Kumar, A Behera, N Damle, M Tripathi, A. Gogia CS Bal.Role of 18F-FDG PET/CT in the management of patients with primary breast lymphoma.Journal of Clinical Oncology 34 (15_suppl), e19073-e19073

• L Kumar, RR Boya, R Pai, B Sainath, RK Sahoo, PS Malik, A Mookerjee, A. GogiaAutologous stem cell Transplantation (ASCT) for Multiple Myeloma (MM): Predictors of long term outcome. Journal of Nuclear Medicine 57 (supplement 2), 1623-1623…2016

• A Singh, S Purkait, A. Gogia, S Mallick.Non-Hodgkin lymphoma unclassifiable between diffuse large B-cell lymphoma and Burkitt lymphoma. Clinical Lymphoma, Myeloma and Leukemia 15, e146-e147

• R Gupta, L Rani, N Mathur, A. Gogia D Sundar, A Sharma, L Kumar. Impact of DNA methylation and gene expression profile on treatment initiation and treatment free survival in early stage CLL.Clinical Lymphoma, Myeloma and Leukemia 15, e145-e146

• RR Boya, S Bakhshi, A. Gogia RK Sahoo, L Kumar. Prediction of poor mobilization of Peripheral Blood Stem Cells (PBSC) with G-CSF alone, in multiple myeloma (MM) patients undergoing autologous transplantation.Clinical Lymphoma, Myeloma and Leukemia 15, 171-72

• P Mehta, V Raina, L Kumar, A Sharma, S Bakhshi, A. Gogia T Tvsvgk.Nasal NK-T cell lymphoma: 10-year experience of a single institute in India.Journal of Clinical Oncology 32 (15_suppl), 19536

• S Mallick, MR Lone, P Ramteke, S Purokait, A. Gogia. Clinico‐Pathological Profile And Cmyc Immunoreactivity Of Alk Positive Large B Cell Lymphoma: Report Of Nine Cases Hematological Oncology Volume 35, Issue S2,Page 395-6

• Ritu Gupta, Lata Rani, NitinMathur, A. Gogia ADuraiSundar, Atul Sharma, Lalit Kumar.Impact of DNA methylation and gene expression profile on treatment initiation and treatment free survival in early stage CLL. Journal of Clinical Oncology 33 (15_suppl), e22073- e22073

• SK Bhoriwal, SVS Deo, NK Shukla, P Garg, R Kumar, A. Gogia DN Sharma, S Thulkar, S Mathur. 18FDG PET-CT–SUV correlation with molecular subtypes in locally advanced/recurrent breast carcinoma Hematological Oncology Volume 35, Issue S2, Pages, 395-396

• Pankaj Kumar Garg, SV SuryanarayanaDeo, Rakesh Kumar, Nootan Kumar Shukla, Sanjay Thulkar, A. Gogia , Dayanand Sharma, Sandeep R Mathur. Role of FDG PET–CT (Positron Emission Tomography and Computed Tomography) scan in the staging of locally advanced/recurrent breast cancer as a single modality.. Journal of Clinical Oncology Volume 33 e11508Publisher American Society of Clinical Oncology

• CK Das, A Garg, A. Gogia, 533P Docetaxel induced cutaneous toxicity in breast cancer patients.(2016) (Annals of Oncology Volume 27Issuesuppl_9) …

• Prashant Mehta, VinodRaina, Lalit Kumar, Atul Sharma, Sameer Bakhshi, A. Gogia, TilakTvsvgk, BivasBiswas, SiddharthSahai, Surendra Pal Chaudhary, Vijay Murugan, Mehar C Sharma, SandeepMathur, Sanjay Thulkar. Nasal NK-T cell lymphoma: 10-year experience of a single institute in India.Journal of Clinical Oncology Volume 32Issue 15_suppl Pages e19536 Publisher American Society of Clinical Oncology

• C.K. Das, A. Gogia, N.K. ShuklaS. DeoS. MathurD. SharmaPrognostic significance of the derived neutrophil lymphocyte ratio in metastatic breast cancer: A tertiary cancer care center analysis from India. Annals of Oncology, Volume 27, Issue suppl_9, 1 December 2016, mdw577.005,

• Natarajan H, Lalit Kumar, Sameer Bakhshi, Atul Sharma, Madhulika K, Velpandian T, A. Gogia, ShivaramShastri, Yogendra Kumar Gupta. Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in patients with chronic myeloid leukemia.Cancer Research Volume76 Issue14 Supplement Pages2040-2040 Publisher American Association for Cancer Research

• Reddy R, Sharma A, Bakhshi S, A. Gogia, Sahoo R, Yadav CP, Kumar L. Comparison of three leukapharesis machines for harvest of stem cells for autologous transplantation: A prospective study.Journal Of Clinical Oncology 34(15_Suppl) 8024

• H Natarajan, L Kumar, S Bakhshi, A Sharma, T Velpandian, A. Gogia, K Gupta. Imatinib trough levels: A potential biomarker to predict cytogenetic and molecular response in newly diagnosed patients with chronic myeloid leukemia. Annals of Oncology Volume 27 Issue suppl_9 Page 586

• P Mehta, L Kumar, V Raina, A Sharma, S Bakhshi, A. Gogia RK Sahoo, S Pabbi, A Chopra, R Kumar high dose (18 g/m) versus low dose (12 g/m) cytosine arabinoside as consolidation for acute myeloid leukemia. Annals of Oncology 26,85

• CK Das, L Kumar, SR Mallick, A. GogiaPrognostic significance of monocyte-lymphocyte ratio in mantle cell lymphoma.Annals of Oncology.2015; Volume 26 Issue suppl_9

• Ritu Gupta, Lata Rani, NitinMathur, A. Gogia, SreenivasVishnubhatla, Lalit Kumar, Atul Sharma, DivyaDubey, PunitKaur. Analysis of IGHV-DJ gene rearrangement and B-cell receptor stereotypes in chronic lymphocytic leukemia: an Indian study. Leukemia & Lymphoma.2015; Volume 56 Pages 124-125

• R Upadhyay, DN Sharma, AK Gandhi, K Haresh, S Deo, A. GogiaRole of radiation therapy and its impact on survival of male breast cancer patients: experience from a tertiary cancer center. International Journal of radiation Oncology.biology.Physics.2016; 96(2)E 29

• R Reddy, S Bakhshi, A Sharma, R Sahoo, A. Gogia PS Malik, S Iqbal, Poor mobilization of peipheral blood stem cells (PBSC) in patients undergoing autologous stem cell transplantation (ASCT): A prospective study.ClinicalLymphoma, Myeloma and Leukemia.2015; 15, e 171

• S Gajendra, A Chopra, S Kumar, A.Gogia J Chandramohan, S Bakhshi.Immunophenotypic analysis of T-lineage acute lymphoblastic leukemia. CD5 matters.... International Journal of Radiation Oncology.2016;• Biology• Physics 96 (2), E29

• L Kumar, P Ganess, A. Gogia I Ghosh, R Hariprasad. High Dose Chemotherapy With Autologous Stem Cell Transplantation For Multiple Myeloma: What Predicts The Outcome? Journal of Clinical Oncology.2015; 33 (15_suppl), e18013-e18013

• A. Gogia,V Raina , Sharma MC .Survival outcome of patient with primary gastric diffuse large B-cell lymphoma: An Institutional experience from developing country.Annals of Oncology 2014 Volume26 Issue suppl 4

• A. Gogia, V Raina, A Sharma, L Kumar, R Gupta, MC Sharma Incidence of second cancer in patients with chronic lymphocytic leukemia: 13 years experience from single institute.European Journal Of Cancer.2013; 49, S846-S846

• A. Gogia, V Raina, A Sharma, L Kumar, R Gupta, S Gajendra, Significance of smudge cell on blood smear in chronic lymphocytic leukemia patients: A prospective single institutional study from India.European Journal Of Cancer.2013; 49, S207-S208

• Gupta A, N Das, M Dahiya, S Rai, S Singh, VK Prajapati, Gogia A. ... Poster: MM-329: Evaluation of Immunophenotype of the Non-Neoplastic Plasma Cell Compartment and Post-Therapy Immunomodulation to Understand Nuances in MRD Assessment of …Clinical Lymphoma Myeloma and Leukemia (2021), S256

• N Das, Gupta A, M Dahiya, S Rai, S Singh, VK Prajapati, RK Sahoo, Gogia A. :-...Poster: MM-359: Pattern-Based Identification of Normal and Aberrant Plasma Cell Compartment across a Spectrum of Plasma Cell Proliferative Disorders Using Multiparametric Flow …Clinical Lymphoma Myeloma and Leukemia (2021), S256

• Mansouri L, Thorvaldsdottir B, Sutton LA, Meggendorfer M, Nadeu F, BrieghelC,Parker H, Laidou S, Moia R, Rossi D, Catherwood M, A.Gogia Different PrognosticImpact of Recurrent Gene Mutations in IGHV-Mutated and IGHV-Unmutated ChronicLymphocytic Leukemia: A Retrospective, Multi-Center Cohort Study By Eric, theEuropean Research Initiative on CLL, in Harmony. Blood. 2021 Nov 23;138:2617.

• A.Gogia, A. Sharma, V. Raina, L. Kumar, R. Kumar, R. Gupta.Clinico-hematological characteristics and outcome assessment of patients with chronic lymphocytic leukemia: A single-institution study of 285 cases.DOI: 10.1200/jco.2011.29.15_suppl.6584 Journal of Clinical Oncology 29, no. 15_suppl (May 2011) 6584-6584

• A. Gogia, Vinod Raina, Atul Sharma, Lalit Kumar, Mehar C Sharma, Ritu Gupta, Prasenjit Das.Clinical features and outcome of follicular lymphoma: 17 years experience from All-India Institute of Medical Sciences (AIIMS), New Delhi, India.Journal of Clinical Oncology Volume31 Issue15_suppl Pages e19524-e19524 American Society of Clinical Oncology 2012

• A. Gogia,V Raina, BK Mohanti, SVS Deo, NK Shukla, V Sreeniwas.Clinical significance of triple negativity in young breast cancer patients (<= 35 years): A single-institute study from India.European Journal Of Cancer 49, S315-S315 2013

• A. Gogia, V Raina, B Mohanti, S Deo, N Shukla Pattern and Survival of Lung Metastasis In Young Breast Cancer Patients: A Single Centre Experience Publication date2013/5/1. Journal Lung Cancer, Volume80,PagesS41, DBT -Travel Grant,Wclc, Sydney, Australia,2014

• A. Gogia,V Raina, SVS Deo, BK Mohanti, NK Shukla, S Venkat. An overview of very young breast cancer patients. The Breast, Volume21, PagesS15,SIOP-Travel Scholarship,Dublin 2018

• A. Gogia V Raina, SVS Deo, BK Mohanti, NK Shukla. Profile Of Male Breast Cancer: Single Institution Study Of 76 Patients from Northern India. Annals Of Oncology, Volume23, Pages110-110, young investigator award,Saintgallen Breast Cancer Conferance 2013.

• A. Gogia, A Sharma, V Raina, L Kumar, R Gupta, R Kumar. An Overview Of Young Chronic Lymphocytic Leukemia Patients: A Single Centre Experience Of 117 Cases From Northern India Annals Of Oncology, Volume 23, Pages 358-358, ICMR-TRAVEL GRANT,ESMO-2013,Amsterdam.

• S Roy, A Biswas, A Binjola, M Tripathi, R Kumar, S Bakhshi, R Sahoo, A. Gogia. Early Clinical Outcome, Acute Toxicity Profile And Health Related Quality Of Life After Chemo-Immunotherapy And Involved Site Radiotherapy (ISRT) In Early Nodal DLBCL-Results ..,International Journal Of Radiation Oncology, Biology, Physics.2020; 108 (3), S156-S157

• S Jain, S Mallick, P Ramteke, A. Gogia M Agarwal, J Dass, R Yadav. Pandora Box Of Lymphomas In Spleen. ...Hematology Reports.2020; 12 (s1)

• S Jain, A Goswami, P Ramteke, Mc Sharma, A. Gogia, A Sharma. Tcl-362: Clinicopathological Profile Of Peripheral T-Cell Lymphoma-Nos And Angioimmunoblastic T-Cell Lymphomas., ...Clinical Lymphoma, Myeloma And Leukemia.2020; 20, S256-S257

• Ck Das, A. Gogia, L Kumar, A Sharma, S Thulkar, I Xess, K Madan. Evaluation Of Pulmonary Infiltrate In Febrile Neutropenic Patients Of Hematologic Malignancies. Indian Journal Of Medical And Paediatric Oncology.2019; 40 (03), 386-390

• R Pramanik, H Kancharla, S Bakhshi, A Sharma, A. Gogia, P Malik.Engraftment Syndrome: A Retrospective analysis of the experience at atertiary care Institute,Clinical Hematology International.2019; 1 (2), 114

• M Sharma, A. Gogia, Svs Deo, S Thulkar, RkPhulia, Ps Malik, S Mathur. Prognostic And Predictive Factors of Outcome In Metastatic Breast Cancer In India: Experience From A Dedicated Breast Cancer Clinic Of A Tertiary Health Care Center. The Breast.2019; 44, S61

• A. Gogia, V Raina, S Deo, D Sharma, S Mathur. Survival Outcome Of Pregnancy Associated Breast Cancer In Resource Limited Country: An Analysis. The Breast.2019; 44, S64

• A. Gogia, S Deo, S Mathur, D Sharma, R Gupta. Predictive Significance Of Derived Neutrophil To Lymphocyte Ratio With Neo-Adjuvant Chemotherapy In Triple Negative Breast Cancer: A Single Center Analysis. The Breast.2019; 44, S26

• A. Gogia, V Raina, S Deo, N Shukla, B Mohanti, D Sharma, S Mathur. Neoadjuvant Chemotherapy For Young (</= 35 Years) Locally Advanced Breast Cancer Patients: Association Of Pathological Complete Response With Survival. An Institutional … The Breast. 2019; 44, S128

• M Sharma, A. Gogia Svs Deo, S Thulkar, RkPhulia, Ps Malik, S Mathur. Oligo-Metastatic Breast Cancer: Real World Scenario From A Single Center In India. The Breast. 2019; 44, S60

• R Singh, S Kumar, A. Gogia, D Sharma, S Deo. Impact Of Tumor Size On Prediction Of Pathological Complete Response After Neoadjuvant Chemotherapy In Breast Cancer. The Breast. 2019; 44, S70-S71

• R Singh, S Bhoriwal, A. Gogia, D Sharma, S Deo. Routine Cavity Shave During Breast Conservation Surgery Is A Good Alternative To Frozen Sections. The Breast. 2019; 44, S110-S111

• A Biswas, N Adhikari, A. Gogia, R Sahoo, A Garg, M Sharma, S Bhasker. High Dose Methotrexate Based Chemotherapy And Response Adapted Whole Brain Radiation Therapy In Primary Cns Lymphoma...International Journal Of Radiation Oncology, Biology, Physics. 2018; 102 (3), S192

• N Adhikari, A Biswas, A. Gogia, A Phase II Trial Of Response Adapted Whole Brain Radiotherapy After High Dose Methotrexate Based Chemotherapy In Patients With Newly Diagnosed Primary Central Nervous System … Annals Of Oncology. 2018; 29, Ix22

• R Sahoo, M Patekar, N Adhikari, A Biswas, V Raina, L Kumar, A Sharma, A. Gogia, .Primary Central Nervous System Lymphoma In India: A 17-Year Experience From Aiims. ...Clinical Lymphoma, Myeloma And Leukemia. 2018; 18, S286

• S Mallick, Mr Lone, P Ramteke, S Purokait, A. Gogia, A Batra, S Bakhshi. Clinico‐Pathological Profile AndCmyc Immunoreactivity Of Alk Positive Large B Cell Lymphoma: Report Of Nine Cases. ...Hematological Oncology. 2017; 35, 395-396

• V Ramalingam, S Hari, Sb Paul, S Thulkar, S Vyas, A. Gogia, Svs Deo. Assessment Of Response To Neo-Adjuvant Chemotherapy In Breast Carcinoma Using Shear Wave Elastography., ...European Congress Of Radiology-2017; Ecr 2017

• Ck Das, A. Gogia, Nk Shukla, S Deo, S Mathur, D Sharma. 121p Prognostic Significance Of The Derived Neutrophil Lymphocyte Ratio In Metastatic Breast Cancer: A Tertiary Cancer Care Center Analysis From India. Annals Of Oncology. 2016; 27, Ix36

• A. Gogia, V Raina. An Update Analysis Of Rituximab Based Chemotherapy In Chronic Lymphocytic Leukaemia Patients: An Indian Scenario. Haematologica. 2014; 99, 585-585

• A. Gogia, V Raina, A Sharma, L Kumar, R Gupta, S Vishnubhatla. Smudge Cells On Routine Blood Smear Predict Clinical Outcome In Chronic Lymphocytic Leukemia: An Institutional Study., ...Leukemia& Lymphoma. 2013; 54, 5-6

• A. Gogia, V Raina, S Deo, B Mohanti, N Shukla. An Overview of Male Breast Cancer: 17 Years experience From A Single Centre. Breast. 2013; 22, S47-S47

• R Upadhyay, DN Sharma, AK Gandhi, K Haresh, S Deo, A. Gogia, .Role of radiation therapy and its impact on survival of male breast cancer patients: experience from a tertiary cancer center. …International Journal of Radiation Oncology, Biology, Physics. 2016; 96 (2), E29

• N Harivenkatesh,L Kumar, S Bakshi, A Sharma, M Kabra, T Velpandian, A. Gogia, .Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in patients with chronic myeloid leukemia. - Cancer Research. 2016; 76 (14 Supplement), 2040-2040

• A. Gogia,V Raina, A Sharma, L Kumar. Safety and efficacy of rituximab based chemotherapy in chronic lymphocytic leukaemia patients: A single centre experience. European Journal of Cancer. 2013; 49, S844-S845

• H Imran, T Pranay, S. V. S. Deo, A. Gogia,A study of PIK3CA gene mutation and its association with hormone receptor positive and HER2 receptor negative in breast cancer patients". Conference Paper. October 2017. 1st Annual Indian Breast Cancer Conference

 

BOOK CHAPTERS (5)

• Hormone-dependent Malignancies in Elderly: Endometrium, Breast and Prostate, Text book of Geriatric Medicine 2015

• Role of Autologous Transplant in hematological Malignancies, Recent Advance in Hematology 2016

• Basics of Cancer Biology and Therapy: Update in Onco-Anaesthesia 2019

• Applied Aspects of Systemic Therapy in Breast Oncoplasty and Reconstruction Breast Oncoplasty and Reconstruction: Principles and Practice 2023

• Arora S, Gogia A. Tumour Lysis Syndrome. In: Kumar, V., Gupta, N., Mishra, S.(eds) Onco-critical Care. Springer, Singapore. (2022)

  

 

Photo gallery ( International  Fellowship)

Article in India Today Magazine ( Nov 21, 2016)

 

Photo gallery ( FREE MEDICAL CAMP AT LEH AND DHARAMSHALA)

 

Photo gallery (FREE MEDICAL CAMP AT magdod ,lEH,AWARD)